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Abstract 
 
This dissertation describes several different chemical-scale studies of proteins 
involved in cellular signaling. The primary focus of this work is on ligand-gated ion channels, 
an important family of membrane receptors. In each study, the incorporation of structurally 
diverse non-canonical amino acids have been used to attain a high level of precision in 
probing the mechanisms of molecular processes. The first chapter provides an introduction 
to the nonsense suppression methodology used to genetically encode these probes, and 
surveys the classes of proteins studied herein. 
The second and third chapters are concerned with the mechanism of activation of a 
prokaryotic receptor, Gloeobacter violaceus ligand-gated ion channel. In these experiments, 
novel histidine derivatives were designed, synthesized, and incorporated to test the 
functional importance of acid-base titration at several positions in the receptor. Then, a 
battery of proline analogs were used to identify necessary structural features of several 
critical proline residues, providing clues to conformational changes that occur during 
receptor activation. 
The fourth chapter discusses studies of a different class of receptors, the Acid-
Sensing Ion Channels. Several fluorinated aspartic acid and glutamic acid derivatives were 
targeted to modulate the acidity of putative proton binding sites. Attempts at preparation of 
these compounds for incorporation into proteins are detailed. Additional sections describe, 
efforts to elucidate factors in the binding selectivity of the tarantula venom psalmotoxin and 
selectivity of cation permeability. 
In the final chapter, early efforts at developing crosslinking assays for protein-protein 
interactions in mammalian cells are outlined. These assays involve the introduction of 
orthogonal tRNA/synthetase pairs for genetically encoding photoreactive phenylalanine 
 xiv 
analogs. The most successful studies involve the ligand-dependent dimerization of the 
soluble nuclear receptor, estrogen receptor α. However, the ultimate goal of this work is to 
to probe protein-protein interactions among membrane receptors and other proteins. 
Progress toward extension of the photocrosslinking assay into membrane receptors is 
described.
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Chapter 1: Introduction 
1.1 Signal transduction in neuronal cells: the ligand-gated ion channels 
Communication among cells in the nervous systems of higher organisms is 
conducted by electrochemical impulses called action potentials (Figure 1.1).1 These signals 
propagate down the length of a neuron, and then stimulate or inhibit other action potentials 
in thousands of neighboring neurons at regions of cellular contact, called synapses. This 
process, which gives rise to sensory perception, muscle control, and conscious thought, is 
coordinated by the release of small-molecule neurotransmitters at the synapse. Each 
neurotransmitter activates particular membrane-bound proteins on the post-synaptic cell, 
triggering a corresponding response. A major aim of our work as a molecular neuroscience 
lab has been to illuminate the chemical-scale factors that influence neurotransmitter binding 
and receptor activation in the context of neuronal signaling. This dissertation details the 
development and implementation of several novel tools for this purpose.  
Among the proteins involved in synaptic transmission are ion channels – membrane-
spanning proteins that mediate the spontaneous flow of ions into or out of the cell. Ion 
channels may be constitutively active,2 or may be opened by a small-molecule ligand,3,4 a 
mechanical stimulus,5 or a change in the local membrane electrochemical potential.6   
 
Figure 1.1. Synaptic transmission and ligand-gated ion channels. pLGICs mediate the relay of an action potential 
from one neuron to the next by binding to small-molecule neurotransmitters released during an action potential.   
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The studies in this work are mainly concerned with ligand-gated ion channels 
(LGICs). In most cases, a neurotransmitter binds to an LGIC at a pocket in the extracellular 
domain of the protein. The noncovalent interactions made by the ligand at this site then 
enable the channel to undergo a transition into an ion-conducting state. The resulting 
current produces a depolarization or hyperpolarization of the membrane, which respectively 
favors or disfavors initiation of an action potential.  
The LGICs are phylogenetically diverse and can be categorized by their structures, 
ligand specificity, and other functional characteristics. Here we focus on two classes of 
LGICs – the pentameric ligand-gated ion channels and the acid-sensing ion channels.  
1.1.1 Pentameric ligand-gated ion channels 
The pentameric ligand-gated ion channels (pLGICs) are present in the nervous 
systems of bilaterally symmetric animals, as well as some prokaryotes.3,4 In animals, pLGICs 
include the excitatory, cation-selective nicotinic acetylcholine receptors (nAChRs)7 and type 
3 serotonin receptors (5-HT3Rs),8 and the inhibitory, anion-selective glycine receptors 
(GlyRs),9 type A γ-aminobutyric acid receptors (GABAARs),10 and glutamate-gated chloride 
channel (GluCl).11 nAChRs are well known for mediating signaling at the neuromuscular 
junction, as well as for their key roles in nicotine addiction, Parkinson’s disease, and other 
neurodegenerative and psychological disorders.12 Thus, they have been important targets for 
medicinal chemists and a dominant subject of research in our lab. 
Efforts to control the activity of pLGICs have been heavily guided in recent years by 
emerging structural data (Figure 1.2). Until 2001, knowledge of the ligand-binding sites was 
based upon mutagenesis and biochemistry experiments.13 At this point, the first X-ray 
diffraction data were obtained for acetylcholine binding proteins, soluble proteins with high 
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structural homology to the ligand-binding domain of the nAChRs.14,15 Advances in 
techniques for the purification of oligomeric membrane proteins and in cryo-electron 
microscopy have since increased the feasibility of obtaining high-resolution structures of 
full-length eukaryotic receptors, yielding data for the muscle-type torpedo nAChR,16 
Caenorhabditis elegans GluCl,11 mouse 5-HT3AR,17 homomeric human β3 GABAAR,18 and 
human α3 GlyR.19  
The pLGICs share a common global architecture, comprising five identical or 
homologous subunits arranged in a barrel configuration around a C5-axis of 
pseudosymmetry. Each subunit bears a large N-terminal extracellular domain primarily 
consisting of β-strands, a membrane-spanning domain made up of four α-helices (M1-M4), 
and a highly variable intracellular M3-M4 loop. In nearly all pLGICs, the ligand-binding site 
is at a conserved location at the interface of subunits in the extracellular domain.20 Extensive 
Figure 1.2. Structures of the pentameric ligand-gated ion channels. (Left) Cryo-EM structure of the nicotinic 
acetylcholine receptor from the Torpedo marmorata electric organ (PDB 2BG9). (Center) The prokaryotic proton-activated 
ion channel from Gloeobacter violaceus (PDB 3EHZ) has been most extensively structurally characterized. (Top right) The 
soluble acetylcholine binding protein from Lymnaea stagnalis (PDB 1UX2) has provided a convenient model for the ligand-
binding domain. (Bottom right) Cross-section of the transmembrane domain from GLIC (PDB 3EHZ). 
 4 
mutagenesis experiments in many pLGICs have allowed us to rationalize trends in ligand 
potency and selectivity based on noncovalent binding interactions.21  
A more challenging goal has been to obtain a chemical-scale model of the protein 
movements that occur during pLGIC activation. The kinetic and thermodynamic parameters 
of these transitions are critical to the tuning of receptor activity by allosteric modulators and 
interactions with other proteins. Understanding the energetic landscape of receptor 
activation will be key in the design of modulating ligands and treatment of disease states. 
However, global changes in protein shape are often more difficult to probe using site-
directed mutagenesis than local noncovalent interactions.  
In 2004, the discovery of prokaryotic pLGICs that are more conducive to 
crystallization enabled the resolution of receptors under a number of different conditions, 
yielding structures that are thought to represent several mechanistically relevant states.22-26 
These channels, Gloeobacter ligand-gated ion channel (GLIC) and Erwinia ligand-gated ion 
channel (ELIC) share the same global architecture as the eukaryotic receptors, but lack the 
large intracellular M3-M4 loop. GLIC has garnered an especially large amount of attention, 
with over 50 PDB structures available. This wealth of information provides a convenient 
testing ground to reconcile functional models obtained using structural and 
electrophysiological approaches. Studies of GLIC therefore constitute a significant portion 
of the work described herein.  
Although most pharmacological characterization of pLGICs is performed on 
individual receptors expressed in heterologous model systems, interactions among pLGICs 
and other endogenous proteins are well documented. These proteins include other LGICs, 
such as the purinergic P2X receptors,27-41 cytoplasmic G proteins,42-44 and extracellular 
proteins, such as the three-finger snake neurotoxins and the endogenous nAChR modulator 
 5 
Lynx1.45 We are interested in developing temporally and spatially controlled assays for the 
investigation of such complexes, and our progress toward this aim will be discussed.  
1.1.2 Acid-sensing ion channels 
Reductions in extracellular pH in the nervous system can occur under a number of 
conditions including neurotransmission by acidic vesicles, inflammation, or restriction of 
blood supply (ischemia).46 Application of low-pH stimulus to some neurons is known to 
produce action potentials, and in many of these cases, pH sensitivity has been linked to a 
class of receptors known as the acid-sensing ion channels (ASICs).47 Studies of ASICs have 
revealed connections with mechanisms of nociception and mechanosensation in sensory 
neurons.48,49 Mouse behavioral models for fear, anxiety, and learning have pointed to 
possible CNS-related roles for ASICs in synaptic plasticity and in susceptibility to psychiatric 
disorders.46,50,51  
Several X-ray crystal structures of members of the ASIC family are available, 
depicting the receptor in what have been interpreted as three different functional states 
(Figure 1.3).52-56 These structures show a pseudosymmetric trimer, with each subunit having 
cytoplasmic N- and C-termini, two membrane-spanning α-helices, and a large extracellular 
domain. It is challenging to identify the site(s) of ligand binding from structural data alone, 
as ASICs are activated by protons rather than small-molecule ligands. However, along with 
conventional mutagenesis experiments, the structures have highlighted a region of the 
extracellular domain rich in carboxylic acid residues, referred to as the “acid pocket”, which 
has been proposed to be titrated by decreasing extracellular pH.52 These side chains also 
appear to interact with cationic groups on peptide toxin inhibitors, as demonstrated by 
cocrystallization.55,56 
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 Our work on ASICs has used unnatural amino acid mutagenesis to approach several 
different questions about the function of these receptors. These include an investigation of 
the mechanism of proton detection, identification of determinants for binding and 
modulation by a peptide toxin, and structural features influencing the relative permeabilities 
of monovalent cations.  
1.2 Intracellular signaling via transcriptional control: the nuclear receptors 
Signal transduction via small molecules can also be mediated by soluble protein 
receptors. Many hormones operate by directly binding to transcription factors called nuclear 
receptors, which in turn modulate gene expression by associating with DNA and recruiting 
other transcriptional machinery.57 
Our group has sought to gain insight into the function of estrogen receptor α (ERα), 
which is classified as a Type I nuclear receptor (Figure 1.4A).58 ERα resides in the  
Figure 1.3. The acid-sensing ion channels. (Left) A cartoon representation of the subunit architecture of ASIC1a. 
(Center) Side and top views of the quaternary structure of ASIC1a homotrimers. The bottom pane shows the binding site 
for psalmotoxin, a peptide tarantula venom. (Right) Zoomed in view of the “acid pocket”, with residues potentially 
involved in pH sensitivity highlighted.   
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nucleus in its resting state as a complex with heat shock protein 90 and several other co-
chaperones, maintaining a conformation that allows binding of steroid hormones.59 Upon 
ligand binding, ERα dissociates from the chaperone complex and forms a homodimer, 
which can interact with various coactivators or inhibitors. These cofactors influence the 
ability of ERα to modulate transcription of genes under the control of an estrogen response 
element (ERE).  
Each Type I nuclear receptor is composed of architecturally conserved DNA-
binding and ligand-binding domains connected by a disordered linker, along with 
unstructured N- and C-terminal regions. Crystal structures of the DNA-binding and ligand-
binding domains have revealed the regions of the protein that are involved in dimerization 
interfaces (Figure 1.4B).60,61 They have also provided evidence for conformational changes 
induced by agonist or antagonist binding, which are thought to confer the differential effects 
of the ligands on gene expression.62-64 Validation of these mechanisms has mostly been 
driven by assays confirming the general colocalization of proteins (e.g. FRET 
experiments),65,66 or by indirect assays that depend on downstream activity (e.g. production 
of reporter proteins).67 We are interested in developing higher-resolution methods for 
probing the specific structural transitions that are relevant in the cellular environment during 
Figure 1.4. Structure and function of estrogen receptor α. (A) Schematic of the canonical mechanism of action for 
ERα. (B) Cartoon representation of the DNA-binding (PDB 4AA6) and ligand-binding domains of ERα (PDB 1A52). 
Other domains are disordered and represented by dashed curves. 
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activation. The approach we have selected will be discussed in detail in section 1.3.3 and 
Chapter 5.  
1.3 Tools for mechanistic analysis of signaling proteins 
1.3.1 Non-canonical amino acid mutagenesis 
Site-directed mutagenesis has been an invaluable technique for biochemists, allowing 
for the identification of specific chemical functionalities that confer function to a protein. 
However, the level of precision afforded by this tool is limited by the selection of amino 
acids encoded by the standard genetic code. Expansion of the genetic code to enable 
incorporation of non-canonical amino acids into proteins in living cells has enabled our 
group and others to approach mechanistic quandaries about proteins from the perspective of 
an organic chemist.68,69 Introduction of subtle structural modifications has unambiguously 
identified critical noncovalent interactions and conformational requirements;70,71 biochemical 
affinity handles or fluorescent dyes have been installed for isolation or imaging purposes;72,73 
and side chains with desired chemical reactivity, such as strain-promoted cycloadditions or 
photochemical radical crosslinking, have frequently been incorporated.74 
Site-specific non-canonical amino acid mutagenesis is accomplished via nonsense 
suppression – the interruption of a ribosomal response to a nonsense mutation (i.e. a stop 
codon or frameshift mutation intervening in a gene).68,75,76 Nonsense suppression depends 
upon the presence of an engineered “suppressor tRNA” that recognizes the chosen 
nonsense mutation during translation and incorporates a non-canonical amino acid at the 
site of the mutation (Figure 1.5A). It is critical that the suppressor tRNA be orthogonal to 
the host system to prevent charging by endogenous aminoacyl tRNA synthetases
 9 
 
and misincorporation of canonical amino acids at the desired position.  
Two methods are generally used to generate charged suppressor tRNA. In the first, 
the non-canonical amino acid is chemically appended to the suppressor tRNA (Figure 
1.5B). To ensure that the amino acid is attached at the proper site, it is reacted with a dCA 
dinucleotide mimicking the final two bases in every tRNA. This aminoacyl dCA is then 
enzymatically ligated with the remainder of the tRNA and introduced into the system. The 
chemical acylation method provides a great deal of flexibility in the functionalities that can 
be incorporated, with the drawback that the yield of protein depends stoichiometrically upon 
the quantity of charged tRNA supplied.  
In the second method, the suppressor tRNA is introduced together with an 
engineered aminoacyl tRNA synthetase that selectively recognizes the suppressor tRNA and 
charges it preferentially with the desired non-canonical amino acid (Figure 1.5C). Again, it is 
important that both the tRNA and the synthetase are orthogonal to the endogenous tRNAs 
Figure 1.5. Non-canonical amino acid mutagenesis via nonsense suppression. (A) An engineered suppressor tRNA 
can insert nonproteinogenic amino acid analogues at the site of a nonsense mutation, allowing for expansion of the genetic 
code. (B) Suppressor tRNAs can be prepared in advance by chemically appending the amino acid of interest to a dCA 
dinucleotide, which is then enzymatically ligated to the remainder of the tRNA. (C) Aminoacyl suppressor tRNA can be 
prepared in situ by providing the expression system with an engineered orthogonal tRNA synthetase.  
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and synthetases, to prevent the frequent misincorporation of amino acids. Such a tRNA-
synthetase pair often requires a great deal of optimization through rational mutagenesis 
and/or directed evolution. This system is therefore convenient for encoding a limited 
number of amino acids previously optimized by other research groups. However, the 
regeneration of charged tRNA enables the production of much larger quantities of desired 
protein product, constituting a distinct advantage over the chemical acylation method. In this 
dissertation, both methods have been used at various points for different applications.  
1.3.2 Electrophysiology  
Since the late 1970s, molecular neuroscience has relied heavily upon 
electrophysiology as a tool for the study of ion channels.77 This family of techniques 
evaluates the properties of proteins, neurons, and neural networks by observing electrical 
currents and potentials across lipid bilayers. Electrophysiology can be used to investigate 
endogenous activity in living animals, channels expressed in heterologous systems, or 
channels reconstituted into artificial membrane bilayers. As our research interests are 
centered on the relationship between chemical structure and protein function, the work 
described here examines the function of LGICs through heterologous expression in two 
systems: oocytes from Xenopus laevis (the African clawed frog) and cultured human cells.  
X. laevis oocytes are a classic model system for pharmacological characterization of 
ion channels, due to their economy, convenient size, and relatively robust expression of 
eukaryotic proteins.78 Protein expression is carried out by microinjecting the appropriate 
mRNA or plasmid cDNA into the cells, followed by an incubation period during which the 
cells perform translation, assembly, and surface trafficking of receptors (Figure 1.6). This 
system is amenable to the nonsense suppression methodology, as chemically acylated tRNA 
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can be easily coinjected along with the gene containing the nonsense mutation.  
In mammalian cells, LGIC expression is accomplished using standard transfection 
vectors and reagents. An additional plasmid can be cotransfected to allow transcription of a 
suppressor tRNA and expression of an engineered synthetase for the purpose of nonsense 
suppression. Following transfection, the cells are incubated in a solution containing the 
desired non-canonical amino acid, which then permeates the plasma membrane and is 
recognized by the engineered synthetase.  
Different aspects of LGIC function may be illuminated using various 
electrophysiological assays. In the projects discussed here, the primary goals of our 
experiments in X. laevis oocytes were to verify functionality of mutants and reveal any effects 
that the mutations induce upon the receptors’ conformational equilibria. A simplified model 
of the activation process is shown in Figure 1.6: the cooperative binding of one or more 
agonist molecules allows the receptor to access an ion-permeable state, a process referred to 
as gating. Mutations that influence the energetics of agonist binding or gating are expected to 
shift these equilibria, resulting in an increase or decrease in the sensitivity of the LGIC to its 
agonist.79 
Figure 1.6. Nonsense suppression in Xenopus laevis oocytes. Ligand-gated ion channels containing non-canonical 
amino acids are expressed by coinjecting oocytes with charged suppressor tRNA and mRNA with a nonsense mutation at 
the site of interest. After expression, mutants are assayed for function using a dose-response electrophysiology assay in two-
electrode voltage clamp mode. C = closed, O = open, A = agonist.  
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This effect can be quantified by measuring the current passing through the 
population of receptors occupying the open state. Such a whole-cell current measurement 
can be quite easily obtained using the two-electrode voltage clamp (TEVC) configuration. In 
this setup, two glass electrodes impale the cell. The first measures the internal potential of 
the cell relative to an external reference electrode in the solution bathing the oocyte, while 
the second electrode responds to fluctuations in this voltage by injecting an appropriate 
current to maintain a “clamped” membrane potential difference. Monitoring this injected 
current provides an indication of the charge passing through channels in the open state, a 
quantity proportional to the number of activated LGICs. Our group is fortunate to have an 
eight-channel recording rig with simultaneous voltage-clamping, buffer perfusion, and liquid 
handling abilities, dramatically increasing the throughput of our TEVC experiments in 
oocytes.  
Typically, a dose-response experiment is performed in which an oocyte expressing 
the LGIC is treated with various concentrations of agonist. The resulting whole-cell currents 
are plotted, normalizing to the maximal current observed (Figure 1.6). These data are fit to 
the Hill equation, which provides a simplified model for cooperative ligand binding:  
 𝐼 𝐴 = $max() [+]EC/0 1H	, (Eq. 1.1) 
where I is the whole cell current, [A] is the agonist concentration, Imax is the current observed 
at saturating concentrations of agonist, EC50 is the agonist concentration eliciting a half-
maximal response, and nH is the Hill coefficient. The EC50 is then used as a readout for the 
magnitude of the energetic perturbation caused by the mutation, where  
log(fold-change in EC50) varies roughly linearly with the ΔΔG value.  
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In some cases, we wish to determine whether a particular perturbation originates 
from disruption of a specific interaction. We often proceed by performing a double mutant 
cycle analysis, in which the effects of two mutations expected to disrupt the interaction are 
observed alone and in combination (Figure 1.7). If the values for log(fold-change in EC50) 
from the two mutations are additive, it appears that the effects of the modifications are 
independent of one another. If the values are significantly nonadditive, then the mutated 
positions are interpreted to interact in either a cooperative or a redundant fashion, 
depending on the magnitude of the coupling parameter: 
 Ω =	 EC/0 mut7,9 	•	EC/0 WTEC/0 mut7 	•	EC/0 mut9  . (Eq. 1.2) 
 Although similar electrophysiology techniques are commonly used to assay LGICs 
in mammalian systems, these experiments are much more difficult to automate. We have 
made use of an alternative technique that indirectly records the membrane potential from a 
monolayer of adherent cells. In this, the fluorescent imaging plate reader (FLIPR) assay, a 
commercial membrane potential dye is loaded into the cells following expression of the 
LGICs of interest.80 Quenching of the dye is reduced by membrane depolarization, due to 
reorientation of the dye molecules in the lipid bilayer. Thus, the activation of ion channels 
Figure 1.7. Double-mutant cycle analysis. If the functional perturbation caused by mutation 1 is identical in the absence 
or presence of mutation 2, the effects are additive and therefore independent. Nonadditivity indicates functional coupling 
of the mutations.  
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can be visualized by changes in fluorescence of the dye in response to the application of 
various concentrations of ligand. Compared with the TEVC, the lack of a voltage clamp in 
the FLIPR assay makes it somewhat challenging to quantitatively interpret the influence of 
mutations on channel activation equilibria. Nevertheless, it is a simple and reliable tool for 
validating the functionality of mutants, monitoring relative expression levels, or comparing 
agonist sensitivities.  
1.3.3 Probing protein-protein interaction interfaces 
Proper operation of most proteins is contingent upon interactions with other 
biomacromolecules. Our understanding of protein-protein interactions among soluble 
proteins is dramatically advanced by the ability to cocrystallize them and obtain X-ray 
diffraction data. However, the acquisition of reliable structures of membrane protein 
complexes is hampered by the dependence of their conformation on their lipid environment, 
especially in cases where associations are weak and transient. Because LGICs are poised to 
transition among several conformations upon association of a small molecule, it is to be 
expected that crystal structures may not be capable of revealing all physiologically important 
details.  
Chemical crosslinking offers a unique solution to this problem. An unobtrusive 
crosslinking group allows proteins to associate normally, and then irreversibly links them at a 
site of contact, preserving information about the interaction of interest even after extraction 
out of the cellular environment (Figure 1.8). An ideal experimental setup should feature 
both temporal and spatial resolution. Temporal resolution requires a trigger for the 
crosslinking reaction, most conveniently supplied by an external UV light source to initiate 
decaging of a reactive group or generation of a reactive radical intermediate. Different 
extents of spatial resolution can be accomplished in several ways. Chemoselectivity is 
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exploited in many cases to reduce the complexity of crosslinked product mixtures – for 
example, an accessible reactive cysteine or lysine residue can be introduced at a position of 
interest and used in conjunction with an amine- or thiol-reactive bifunctional crosslinker. 
However, the most precise method of spatial resolution uses the site-specific installation of a 
crosslinker.  
Other groups have previously established a convenient procedure for doing this 
using nonsense suppression with engineered tRNA/synthetase pairs.81,82 In our crosslinking 
experiments, we have made use of two such pairs optimized for 4-benzoylphenylalanine and 
4-azidophenylalanine. These are UV-activated zero-length crosslinking groups with 
somewhat differing modes of reaction and chemoselectivity, which will be described in detail 
in a later chapter. Due to the minor steric perturbation these probes impose relative to 
phenylalanine or tyrosine, we have selected them as the optimal choice for our investigation 
of protein-protein interaction interfaces.  
Figure 1.8. Probing protein-protein interfaces with site-specific crosslinking. Photoreactive crosslinking amino acids 
are incorporated at positions of interest using nonsense suppression. After crosslinking proteins by UV irradiation, cells are 
homogenized, and lysates are processed. Photoadducts are analyzed by SDS-PAGE and/or proteolysis followed by tandem 
mass spectrometry. 
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Following incorporation of the crosslinking amino acids and irradiation to trigger the 
photoreaction, a number of possible approaches can be used to extract information from the 
resulting adducts (Figure 1.8). These include various enrichment and fractionation steps, 
electrophoresis and western blotting for visualization, and mass spectrometric analysis. 
While mass spectrometry has in several instances been used in conjunction with crosslinking 
by genetically encoded reagents,83-85 two out of the three studies were carried out in vitro 
with purified proteins, and none involved membrane proteins. This is reflective of the 
challenging nature of the problem, despite the wealth of information that could likely be 
uncovered through improvement of current methods.  
1.4 Summary of dissertation work  
In this dissertation, non-canonical amino acid mutagenesis is used in conjunction 
with other biochemistry techniques to probe the structure and function of proteins with a 
high level of precision. These studies include work on ligand-gated ion channels and nuclear 
receptors, using heterologous model systems from Xenopus laevis and mammalian cell lines.  
Chapters 2 and 3 describe work focused on the prokaryotic proton-gated pentameric 
ligand-gated ion channel, GLIC. These experiments were conducted by expressing mutant 
receptors in Xenopus laevis oocytes and assaying their responses to changes in pH through 
electrophysiology. In Chapter 2, the first incorporation of two unnatural histidine analogs via 
nonsense suppression is presented, and it is demonstrated that this method can be effectively 
applied to determine the functional importance of histidine side chain basicity in a protein. 
Chapter 3 surveys the roles of critical proline sites in GLIC through incorporation of a wide 
array of unnatural amino acid analogs. The observed effects are then discussed in the context 
of other similar proline experiments from our group and the accumulated mechanistic 
knowledge for the pLGIC family. 
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Chapter 4 applies the nonsense suppression methodology to the study of ASIC1a, 
also in the Xenopus laevis oocyte expression system. The attempted syntheses of two 
fluorinated analogs of aspartic and glutamic acid are discussed, and the intended 
experimental design for their use in probing the acid pocket is outlined. Backbone ester 
mutagenesis was used to investigate the importance of carbonyl hydrogen bond-acceptors in 
the ion selectivity filter region of the receptor, and preliminary results of these experiments 
are presented. Attempts were also made to modulate an interaction with the tarantula venom 
psalmotoxin, using a fluorinated phenylalanine residue to probe a possible cation-π 
interaction at the protein-peptide interface. 
Chapter 5 details our group’s first efforts at using site-specific photocrosslinking for 
the characterization of protein-protein binding interfaces. An assay for direct detection of 
ligand-induced dimerization of estrogen receptor α in living mammalian cells is established 
with the aid of an engineered orthogonal tRNA/synthetase pair. Finally, progress towards 
the use of the crosslinking strategy for studying interactions among membrane receptors is 
described. These experiments include the incorporation of photocrosslinking groups into 
nAChRs containing α6 and α4 subunits, as well as into the 5-HT3A homopentamer.  
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Chapter 2: Probing Structural Requirements in the Transmembrane 
Domain of GLIC* 
2.1 Abstract 
The cyanobacterial pentameric ligand-gated ion channel GLIC, a homolog of the 
Cys-loop receptor superfamily, has provided useful structural and functional information 
about its eukaryotic counterparts. X-ray diffraction data and site-directed mutagenesis have 
previously implicated a transmembrane histidine residue (His234) as essential for channel 
function. Here, we investigate the role of His234 via synthesis and incorporation of histidine 
analogues and α-hydroxy acids using in vivo nonsense suppression. Receptors were 
expressed heterologously in Xenopus laevis oocytes, and whole-cell voltage-clamp 
electrophysiology was used to monitor channel activity. We show that an interhelix hydrogen 
bond involving His234 is important for stabilization of the open state, and that the shape 
and basicity of its side chain are highly sensitive to perturbations. In contrast, our data show 
that two other His residues are not involved in the acid-sensing mechanism.   
2.2 Introduction 
Cys-loop receptors are a class of pentameric ligand-gated ion channels (pLGICs) that 
mediate synaptic transmission among neurons in the central and peripheral nervous systems 
of eukaryotes.1,2 The family has been extensively characterized using electrophysiological and 
biochemical techniques, and includes the nicotinic acetylcholine (nACh), glycine (Gly), 
serotonin (5-HT3), and g-aminobutyric acid (GABAA) receptors. These receptors are 
essential for normal neuronal function, and an appreciation of the mechanisms by which 
                                                
 
*Parts of this chapter are adapted with permission from: Rienzo, M., Lummis, S.C.R., and Dougherty, D.A. Structural 
Requirements in the Transmembrane Domain of GLIC Revealed by Incorporation of Noncanonical Histidine 
Analogs. Chem Biol (2014) 21, 1700-1706. © 2014 Elsevier Ltd. 
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they recognize ligands and undergo structural changes associated with channel gating is 
crucial for a full understanding of intercellular signaling in the nervous system. Moreover, 
many Cys-loop receptors have been identified as playing a role in various neurodegenerative 
diseases, establishing them as targets for drug development.3,4 Structure-function studies of 
the Cys-loop family have been guided by electron microscopy images of nAChRs,5 and by 
crystal structures of a family of soluble proteins, the acetylcholine binding proteins, which 
display high sequence homology to the extracellular domain of nAChR subunits.6,7   
Crystallization of full-length Cys-loop receptors has proven to be challenging, and 
the only members of the family for which a high-resolution X-ray crystallography structure 
has been reported are the invertebrate, glutamate-gated chloride channel (GluCl),8,9 the 
human GABAA receptor (β3 subunit homopentamer),10 and recently the mouse 5-HT3 
receptor (A subunit homopentamer).11 There are also two prokaryotic pentameric channels 
whose structures have been solved; they were identified in the cyanobacterium Gloeobacter 
violaceus (GLIC) and the bacterium Erwinia chrysanthemi (ELIC).12-15 GLIC is of particular 
interest for the study of gating transitions, in that its structure has been elucidated in multiple 
conformational states under a number of conditions.15-20 Although molecular details for 
these homologs likely differ from those of eukaryotic Cys-loop receptors (including the fact 
that the Cys-loop is absent), the global conformational changes that occur upon channel 
activation should be informative for the entire family. Τhe prokaryotic proteins thus provide 
an opportunity to study these energetic landscapes in a context where structural data are 
already available.  
Unlike most Cys-loop receptors, activation of GLIC is mediated by titration of 
ionizable residues at low pH, rather than by binding of a small molecule. Direct observation 
of the ligand-binding site(s) via crystallography is therefore not possible, leaving mutagenesis 
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and biochemical probes of the receptor as the best tools to discern which residues are 
responsible for detection of a pH change and how resulting conformational changes are 
propagated to give an ion-conducting state. Recent studies have implicated a transmembrane 
histidine residue (His234 or His11’ using the M2 prime labeling system) as playing an 
essential role in GLIC function.17,21 Specifically, the histidine side chain was proposed to 
form an interhelix hydrogen bond with the backbone carbonyl of Ile258, stabilizing the 
closer association of the M2 and M3 helices that is observed in the open state of the channel, 
compared with locally closed mutants and structures obtained at neutral pH (Figure 2.1). 
Conventional mutagenesis at this histidine has revealed high sensitivity to perturbation, both 
for channel function and surface expression of the receptor. No receptors with point 
mutations at His234 were shown to access an ion-conducting state.21 Additionally, molecular 
dynamics simulations have suggested that protonation of His234 occurs concomitantly with 
a transition to the open state.21 In spite of these insights, a functional, proton-gated fusion 
consisting of the extracellular domain of GLIC and the transmembrane domain from the 
human α1 glycine receptor (which does not contain an analogous His residue) has also been 
reported.22 While functional, this chimera produced a shifted pH-response curve relative to 
full-length GLIC, a more dramatic shift than is typically seen for comparable chimeras of 
Figure 2.1. Histidine residues in GLIC. (A) Crystal structure of GLIC in a presumed open state (PDB 3EHZ). Histidines 
studied here are highlighted. (B) Top-down overlay of a locally closed GLIC mutant structure (blue, PDB 3TLU) with the 
open channel structure (green), omitting the extracellular domain. Note the movement of the M2 helix associated with 
channel opening. (C) Side view overlay of locally closed (blue) and open (green) GLIC structures. The orientation of the 
depicted residues suggests the formation of a hydrogen bond (shown as a dashed line) between His234 and the backbone 
carbonyl of Ile258 upon channel activation. 
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mammalian Cys-loop receptors where extracellular domain activation reasonably mimics that 
of the parent receptor.23,24 Thus, while some aspects of the pH sensitivity of GLIC may be 
conferred by an as-yet-unidentified proton-binding region in the extracellular domain, such a 
region may play a major role only in the chimera. This is reminiscent of proton activation of 
KcsA, where are there are 2 proton sensing regions: His25 in M1 (likely the major sensor) 
and a network of ionizable residues at the transmembrane/cytoplasmic interface.25-28  
Since conventional mutagenesis at His234 is disruptive to GLIC function, we have 
implemented the subtler probe of non-canonical amino acid mutagenesis in the 
transmembrane domain. None of the canonical amino acids closely resemble the properties 
of histidine, and conventional mutagenesis does not allow for modification of the protein 
backbone. The small systematic perturbations to steric and electrostatic interactions enabled 
by non-canonical amino acid mutagenesis could allow for a deeper understanding of the 
origins of its sensitivity to substitution. In this work, we describe the synthesis and 
incorporation of two non-canonical histidine analogues into GLIC; residues designed 
specifically to probe the protonation of His234. In addition, we use backbone mutagenesis 
to probe formation of the M2-M3 interhelix hydrogen bond. Our data suggest that both are 
important for channel function. 
2.3 Results and discussion 
2.3.1 His234 is the only His residue critical for GLIC function 
GLIC is activated when extracellular pH is lowered, and the half-maximal pH for 
activation (pH50) is 5.5, implicating a histidine (pKa ~ 6) as a critical ionizable residue. There 
are three His residues in GLIC (Figure 2.1A), and previous data have shown that mutation 
of either His126 or His234 ablates function, while alteration of His276 does not.21 Thus, 
His126 and His234 were initially proposed as candidates for a proton binding site. However, 
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subsequent expression studies in HEK cells showed that lack of function with His126 
mutants was due to the role of this His in protein folding, subunit oligomerization, and/or 
transport to the cell surface.21 To further probe the importance of this site, we created a 
range of GLIC His126 mutants and evaluated them in Xenopus oocytes, which are often able 
to express proteins that are not amenable to expression in mammalian cells. Our data 
revealed that these mutant receptors are functional, with pH50 and nH values similar to those 
of wild type for nearly all the His126 mutants we tested (Table 2.1). The data therefore 
indicate that His126 is not important for proton activation. Our results also support the 
earlier study that suggested this residue has a role in expression, as we observed very 
different maximal currents for the mutant receptors (Figure 2.2).  
2.3.2 Probing the His234-Ile258 hydrogen bond 
 Crystallographic studies suggest a functionally important hydrogen bond between the 
side chain of His234 on helix M2 and the backbone carbonyl of Ile258 on M3 (Figure 
2.1C). We have frequently employed a general strategy for probing hydrogen bonds to the 
protein backbone, using nonsense suppression methodology to incorporate α-hydroxy acid 
analogues of α-amino acids.29-31 Briefly, a stop codon is introduced at the position of interest, 
and mRNA is prepared by in vitro runoff transcription. The desired α-hydroxy acid is ligated 
Table 2.1. Conventional mutagenesis of His126. (Experiments performed by Prof. Sarah Lummis).  
  
Mutant pH50 Hill Coefficient (nH) 
Number of 
Oocytes 
Tested 
wt GLIC 5.50 ± 0.02 1.4 ± 0.1 16 
H126A 5.24 ± 0.10 2.3 ± 0.3 3 
H126E 5.38 ± 0.07 2.2 ± 0.2 3 
H126K 5.34 ± 0.06 2.0 ± 0.2 3 
H126L NR  3 
H126R 5.40 ± 0.14 2.0 ± 0.4 3 
H126S 5.52 ± 0.05 2.0 ± 0.2 3 
H126Y 5.35 ± 0.04 2.6 ± 0.3 3 
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to a suppressor tRNA bearing the anticodon corresponding to the stop codon used. The 
tRNA and mRNA are then coinjected into Xenopus oocytes, and the cells are incubated to 
allow for expression of the protein containing the α-hydroxy acid.32,33 
The consequences of substitution with an α-hydroxy acid are twofold (Figure 2.3). 
Replacement of a residue with its α-hydroxy analog results in the loss of the backbone N-H 
bond, eliminating hydrogen bond donation. In addition, replacement of the backbone amide 
with an ester diminishes the hydrogen bond-accepting ability of the carbonyl at the i-1 
residue relative to the mutation. Previous studies have shown that both effects can produce 
substantial perturbations of protein function.33 In the present case, to probe the Ile258 
carbonyl we replaced Phe259 with phenyllactic acid (Fah), the α-hydroxy acid analogue of 
Phe.  
The backbone mutation to modulate the proposed M2-M3 hydrogen bond produced 
functional channels that expressed well (Table 2.2). The substitution did result in a shift in 
pH50 by about 1 pH unit toward a more acidic value. This suggests that weakening the M2-
M3 hydrogen bond results in a relative destabilization of the open state of the channel, 
consistent with the model of Figure 2.1. Of course, by introducing a backbone mutation 
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Figure 2.2. Maximal currents observed for mutants at His126. These data were obtained from the same batch of 
oocytes to minimize oocyte variability. Values are relative to wild type (100%); data = mean ± SEM, nH = 3-5. 
(Experiments performed by Prof. Sarah Lummis).  
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near the middle of the M3 α-helix, we are impacting several potential hydrogen bonds. 
Interestingly, in the open channel structure (PDB 3EHZ) there is a distortion of the M3 
helix in the region of the Ile258 carbonyl, such that this carbonyl appears to make a stronger 
hydrogen bond to the M2 His side chain (O•••N distance 3.0Å) than to the backbone NH of 
the i+3 residue in M3 (Tyr262; O•••N distance 3.5Å). At the same time, the NH of Phe259  
(which is deleted in the α-hydroxy experiment) makes a strong hydrogen bond to the i-4 
residue (Gly255; O•••N 3.1Å). When we perturbed this hydrogen bond in the same manner 
– conversion of Ala256 to its α-hydroxy analogue – we were unable to observe functional 
channels. Nonsense suppression can be effective at the Ala256 site, however, as we were 
able to rescue wild type behavior by incorporation of Ala.  Further experiments are required 
to tease out the role of any hydrogen bond networks in this region of the protein, although 
currently there is no evidence to indicate that hydrogen bonds other than those formed by 
His234 are actively involved in channel gating. At present then, we can say that our results 
are consistent with the presence of an important hydrogen bond between the backbone 
carbonyl of Ile258 on helix M3 and the side chain of His234 on helix M2, but we cannot rule 
out other interactions.  
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Figure 2.3. Backbone mutagenesis. Incorporation of phenyllactic acid at Phe259 introduces a backbone ester mutation, 
converting a strong hydrogen bond (solid line) to a weaker hydrogen bond (dashed line). 
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2.3.3 Synthesis and incorporation of non-canonical histidine analogs 
We next hoped to determine the specific molecular requirements at His234 necessary 
for the function of GLIC. In particular, we were curious whether GLIC could tolerate subtle 
changes in the size or basicity of the imidazole side chain of His234. Recall that all 
conventional mutations of His234 produce nonfunctional channels. We first considered 2-
methylhistidine (2-CH3His), an analogue that would be expected to have increased steric 
bulk but only a minor (~0.7 pKa unit) increase in basicity relative to histidine, based upon the 
effect of adding a methyl group to the corresponding position on imidazole.34 For the 
synthesis of the desired non-canonical amino acid, we adapted a literature procedure for 
radical alkylation of histidine (Figure 2.4).35 While the original reaction conditions resulted 
in only trace quantities of 2-CH3His, we found that using acetic acid as a cosolvent and 
increasing the concentrations of silver nitrate and ammonium persulfate provided a low, but 
acceptable yield of the desired product, with high regioselectivity for the 2-position. This 
provided us with relatively rapid access to 2-CH3His, which could then be appropriately 
protected and appended to suppressor tRNA as previously described.30  
 Interestingly, coinjection of H234TAG mRNA with 2-CH3His-charged tRNA gave 
no evidence of functional channels containing 2-CH3His, even after long incubation times 
and multiple injections of large quantities of material. Control experiments in which 2-
CH3His was incorporated at the two other histidine sites (His126 and His276) produced
Table 2.2. Backbone mutagenesis experiments. Effects of perturbation of the interhelix hydrogen bond between 
His234 and Ile258. 
 
Mutant pH50 Hill Coefficient (nH) Number of Oocytes Tested 
F259TAG + Phe 5.54 ± 0.07 1.1 ± 0.1 14 
F259TAG + Fah 4.47 ± 0.07 2.4 ± 0.3 10 
A256TAG + Ala 5.43 ± 0.03 1.6 ± 0.6 8 
A256TAG + Aah NR  8 
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functional channels, establishing that 2-CH3His can be readily incorporated via nonsense 
suppression (Figure 2.5, Table 2.3). Given the modest effect on His pKa caused by CH3-
substitution, we considered these results to suggest that the introduction of even a minimal 
steric clash in the vicinity of His234 may disrupt either protein folding, membrane 
trafficking, or the gating process. 
Examination of structural data from the “open” state of GLIC (PDB 3EHZ) 
suggests possible unfavorable interactions between a group installed at the 2-position of the 
Figure 2.4. Preparation of 2-substituted histidine analogs. Preparation of (top) 2-CH3His and (bottom) 2-CF3His for 
ligation to suppressor tRNA. 
 
 
Figure 2.5. Histidine substitutions at control sites. (A and B) Control experiments demonstrate robust nonsense 
suppression and membrane trafficking with histidine (dotted) and synthetic histidine anlaogs 2-CH3His (solid) and 2-
CF3His (dashed) at His126 (A) and His276 (B). Mean normalized current responses are plotted from 12-20 oocytes per 
condition, with standard error indicated. (C) Space filling models of and 2-CH3-imidazole (top) and 2-CF3-imidazole 
(bottom), showing they are comparable in size.   
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His234 side chain and the side chains of Ile261 and Ile258 (Figure 2.6A). We therefore 
introduced additional mutations in combination with H234TAG in an effort to alleviate 
crowding around the substituted histidine (Figure 2.6B). The I261G mutation alone 
produced functional channels. Concentration-response curves showed some cell-to-cell 
variation (Figure 2.7), but currents are first observed upon acidification at pH 6, and we 
estimate pH50 to be approximately 5.0. Combining the I216G mutation with 2-CH3His 
incorporation at His234 did produce functional channels. The steric sensitivity of this region 
is emphasized by the fact that 2-CH3His did not produce functional channels in the presence 
of the I261A mutation (Figure 2.6B). For the 2-CH3His/I261G double mutant, currents 
were first observed upon acidification at pH 5.5, and increased roughly linearly as pH was 
lowered to 3.5. While the pH profiles of these currents were consistent, the oocytes did not 
tolerate proton concentrations high enough to reach a maximal current. As such, we were 
unable to obtain a reliable pH50 value for this mutant.  
In order to demonstrate that the mechanism of channel activation is not in some way 
modified by the I261G mutation, perhaps via a disruption of the M3 helix, we combined 
I261G with the conventional mutations H234L and H234F, and observed negligible currents    
(data not shown). Thus, His234 still plays an essential role in gating, even in the presence of 
the I261G mutation, and the observed function of the His234(2-CH3His) mutant appears to 
Table 2.3. Effects of nonsense suppression with histidine analogs at non-essential histidine sites. 
Mutant pH50 Hill Coefficient (nH) 
Number of 
Oocytes 
Tested 
H126TAG + His 5.56 ± 0.03 1.5 ± 0.1 13 
H126TAG + 2-CH3His 5.61 ± 0.02 1.6 ± 0.1 21 
H126TAG + 2-CF3His 5.72 ± 0.01 1.6 ± 0.1 18 
H276TAG + His 5.41 ± 0.03 1.7 ± 0.1 12 
H276TAG + 2-CH3His 4.52 ± 0.03 2.2 ± 0.1 15 
H276TAG + 2-CF3His 4.52 ± 0.08 2.7 ± 0.4 16 
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be permitted specifically by reduction of steric bulk in the proximity of the 2-position. Given 
the sensitivity to structural perturbation in the region of His234, we could not expect the 
subtle pKa shift associated with the addition of the methyl group to be discernable. As such, 
Figure 2.6. Histidine substitution at His234. (A) Space-filling model of His234 and surrounding residues in the 
presumed open state structure (PDB 3EHZ).  (B) Whole-cell current responses of oocytes expressing GLIC mutants to 
buffer applications at pH 7.5, 6.5, 5.5, and 4.5. 
Figure 2.7. Representative dose-response data for selected mutants. Each color represents peak current data recorded 
from a single oocyte. Cells expressing receptors containing the I261G mutation gave inconsistent pH-response curves with 
low Hill coefficients. Saturating H3O
+ concentrations were not generally tolerated by the oocytes. 
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we sought a more dramatic electronic perturbation, and we chose 2-CF3His. As shown in 
Figure 2.5C, 2-CH3His and 2-CF3His are similar in size. However, the two have very 
different basicities – while the conjugate acid of 2-methylimidazole has a pKa of 7.75, the 
corresponding value for 2-trifluoromethylimidazole is 2.06.34 Thus 2-CF3His is a very weak 
base that would almost certainly remain in the neutral form at any pH accessible in the 
electrophysiology assay. We therefore prepared 2-trifluoromethylhistidine (2-CF3His) using a 
literature procedure (Figure 2.4),36 and appended it to a suppressor tRNA as described for 
2-CH3His. Again, positive control experiments at His126 and His276 indicated that 
nonsense suppression with 2-CF3His occurs robustly (Figure 2.5B; Figure 2.8). The 
concentration-response curves for the 2-CF3His and the 2-CH3His mutants overlay at both 
sites indicating that: (1) any steric perturbation due to trifluoromethylation is similar to that 
introduced by methyl substitution at these sites and (2) as the pKas of these compounds are 
very different, the protonation state of neither His126 nor His276 affects GLIC function.  
Attempts at incorporation of 2-CF3His at His234 in combination with the I261G 
Table 2.4. Effects of mutation at His234. pH50 and nH data are shown as mean ± SEM. NR, nonresponsive.  
 
 
Mutant pH50 Hill Coefficient (nH) 
Number of 
Oocytes 
Tested 
H234F NR  17 
H234L NR  12 
H234TAG + His 5.37 ± 0.04 1.5 ± 0.1 23 
H234TAG + 2-CH3His NR  20 
I261A 5.05 ± 0.03 1.6 ± 0.1 11 
I261A/H234TAG + His 4.96 ± 0.02 1.3 ± 0.1 15 
I261A/H234TAG + 2-CH3His NR  19 
I261Ga ~ 5.0  ~ 0.9 25 
I261G/H234F NR  17 
I261G/H234L NR  10 
I261G/H234TAG + Hisa ≤ 4.5 ~ 0.8 9 
I261G/H234TAG + 2-CH3Hisa ≤ 4.5 ~ 0.8  14 
I261G/H234TAG + 2-CF3His NR  23 
 aOocytes did not tolerate saturating proton concentrations; pH50 and nH values given are estimated.  
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mutation, however, gave no significant currents. Due to the inherently low expression levels 
associated with nonsense suppression experiments in Xenopus oocytes, it was not possible to 
establish whether receptors were successfully synthesized and delivered to the cell surface by 
immunofluorescence (Figure 2.9). However, given that we have established that 2-CF3His is 
compatible with our nonsense suppression methodology, and that 2-CH3His at this site can 
produce functional receptors, we consider the most reasonable interpretation of the 2-
CF3His results to be that the non-canonical amino acid was incorporated, but that the 
resulting receptors are nonfunctional because protonation cannot occur.  
2.4 Conclusions and recent developments 
Structural and functional data for GLIC have shown the importance of His234 in the 
transmembrane region of this protein. Here we have shown that even subtle steric 
perturbation of His234 will ablate function, and this can be partially rescued by 
compensatory steric alterations in the adjacent M3 helix. In addition, we have produced two 
lines of evidence to support a key role for protonation of His234 in receptor function. First, 
the subtle mutation by backbone mutagenesis of the putative hydrogen bond partner to the 
protonated His234 alters function in the expected direction. Second, introducing a His 
Figure 2.8. Representative current traces for nonsense suppression experiments at His126 and His276. Running 
buffer was at pH 8; responses are shown for acidification to pH 7, 6, 5, and 4, indicated by the black bar. 
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analogue that would not be expected to be protonated at pH > 2 (2-CF3His) produces 
nonfunctional channels. Overall these experiments show that formation of the M2-M3 
hydrogen bond is important for stabilizing the ion-conducting state, and support the in silico 
experiments which show that His234 must exist in the protonated form for GLIC to attain 
its activated conformation.21  
Since the publication of the results described here, additional mechanistic work on 
GLIC by other research groups has further illuminated the role played by His234 and other 
residues. Interestingly, it has been shown that GLIC mutants containing both H234F and 
the gain-of-function mutation I9’A produce large acid-induced currents.37 This indicates that 
His234 is not an indispensible proton binding site for detection of reduced pH. Rather, it is 
likely that destruction of the hydrogen bond examined here causes a relative destabilization 
of the open state too great to be observed within the pH range used in our experiments, but 
one that can be reversed by a strong gain-of-function mutation at another position.  
In the same study, a chimeric receptor consisting of a fusion between the ECD from 
ELIC and the TMD from GLIC was also shown to produce smaller currents induced either 
 
Figure 2.9. Immunofluorescence experiments. Oocytes expressing each mutant were immunolabeled and sliced, then 
imaged by confocal microscopy (see Supplemental Experimental Procedures). While it was possible to verify surface 
expression of the nonfunctional H234F mutant, expression from nonsense suppression experiments was too low to 
distinguish levels of fluorescence from those observed in the negative controls.  
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by reduced pH or by primary amines (the activating ligands for ELIC).37 The currents 
persisted even in the presence of the combined H234F and I9’A mutations. Considered 
together with the previous results involving the GLIC-GlyR chimeras,22 this is further 
evidence that no single proton-binding site in either the ECD or TMD is fully responsible 
for the pH sensitivity of GLIC. In the most likely case, the concerted protonation of a 
number of residues results in global conformational changes during channel activation. 
Taken alone, it is doubtful that either crystal structures or simple mutagenesis experiments 
will be capable of identifying the critical titrated sites, if such a well-defined group of sites 
indeed exists. Future studies of GLIC will require careful coordination of structural, 
biochemical, and computational efforts to develop models for the energetic landscape of the 
receptor in its dynamic membrane environment. 
2.5 Experimental procedures 
2.5.1 Molecular biology 
The cDNA for GLIC was inserted into the pGEMhe plasmid using standard 
subcloning techniques. Site-directed mutagenesis was performed using the Stratagene 
QuikChange protocol to generate the appropriate codon. For non-canonical amino acid 
mutants and conventional mutants generated by nonsense suppression, the site of interest 
was mutated to the TAG stop codon. Plasmids were linearized with the SbfI restriction 
enzyme, and receptor mRNA was then prepared by in vitro runoff transcription using the 
Ambion T7 mMessage mMachine kit. 
  Hydroxy or amino acid-dCA couples were enzymatically ligated to truncated 74mer 
THG73 tRNA as previously described.29,32 The 74mer tRNA was prepared using the 
Ambion T7MEGAshortscript kit by transcription from a modified DNA oligonucleotide 
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template as described in the literature to enhance RNA transcript homogeneity.38 Crude 
tRNA-amino acid or tRNA-hydroxy acid product was used without desalting, and the 
product was confirmed by matrix-assisted laser desorption ionization time-of-flight mass 
spectrometry on a 3-hydroxypicolinic acid matrix. Deprotection of the NVOC group on the 
tRNA-amino acids was carried out by photolysis for 5 minutes on a 300 W high-pressure Hg 
arc lamp with WG-335 and UG-11 filters immediately prior to injection.  
 Note that we are using residue numbering consistent with PDB 3EHZ (Figure 
2.1).15 In some other published structures of GLIC, residues are offset by 1.  
2.5.2 Oocyte preparation and RNA injection 
 Stage V-VI oocytes of Xenopus laevis were harvested and injected with RNAs as 
described previously.32 For nonsense suppression experiments, each cell was injected with 
50-100 ng each of receptor mRNA and appropriate tRNA approximately 48 h before 
recording. Mutants yielding small responses required 72 h of incubation, with a second 
injection of mRNA and tRNA 48 h before recording.  
 For wild type experiments and conventional mutants, each cell received a single 
injection of 1-25 ng of receptor mRNA approximately 24 h before recording. Injection 
volumes for each injection session were 50-100 nL per cell.  
 As a negative control for suppression experiments at each site, unacylated full-length 
tRNA was co-injected with mRNA in the same manner as charged tRNA. These 
experiments yielded negligible responses for all sites. Wild-type recovery conditions 
(injecting tRNA charged with the appropriate amino acid to regenerate a wild type channel 
via nonsense suppression at a TAG stop codon) were injected alongside mutant nonsense 
suppression conditions as a positive control. THG73-phenyllactic acid was unprotected and 
was injected directly without irradiation. 
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2.5.3 Electrophysiology 
Oocyte recordings were made in two-electrode voltage clamp mode using the 
OpusXpress 6000A (Axon Instruments). Oocyte equilibration and washes were performed 
with Ca-free ND96 (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES) adjusted to pH 
8 with 1 N NaOH. The pH of buffers for concentration-response curves were adjusted 
accordingly with NaOH or HCl, and buffers with pH below 6.8 contained 5 mM MES in 
place of HEPES. Initial holding potential was -60 mV. Data were sampled at 125 Hz and 
filtered at 50 Hz. Oocytes were equilibrated for 30 s at 1 mL/min before each pH 
application. The pH buffer applications lasted for 15 s at 4 mL/min, followed by a 15 s wait 
period to allow the cells to attain a peak current. Cells were then washed for 40 s at 3 
mL/min before the following equilibration. Concentration-response data were obtained for 
9 buffer pHs, for a minimum of two cell batches, and for a minimum of 8 cells total. The 
concentration-response relations for each cell were fitted to the Hill equation: 
 𝐼 𝐴 = $max() [+]EC/0 1H,  (2.1) 
where Inorm is the normalized current peak at [H3O+] = A, EC50 is the value of [H3O+] that 
elicits a half-maximum response, and nH is the Hill coefficient. The values for each cell that 
displayed a strong fit to the Hill equation were then averaged to give the reported values, 
where pH50 = -log(EC50). At pH < 4, uninjected cells gave current responses that were 
occasionally up to ~ 200 nA. As such, data were only reported from cells that gave 
responses above pH 4, or that gave larger, more robust currents below pH 4, and other cells 
were considered non-responsive (NR). 
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2.5.4 Immunofluorescence Experiments 
Following injection and incubation, oocytes were fixed in a 3.7% solution of 
paraformaldehyde in phosphate buffered saline (PBS) buffer (0.01 M, pH 7.4) for 3 h. The 
cells were then washed in a 3% solution of bovine serum albumin (BSA) in the same buffer 
(3 x 10 min) at room temperature, and then labeled overnight at 4 °C with monoclonal 
mouse-anti-HA (1:1000 in 3% BSA/PBS). Cells were washed in 3% BSA/PBS at room 
temperature (3 x 10 min), then incubated 3 h at room temperature with anti-mouse IgG 
secondary antibody conjugated with Alexa Fluor 555 (1:500 in 3% BSA/PBS). Cells were 
then washed in PBS buffer (3 x 5 min) and embedded in blocks of 3% low melting agarose 
in PBS buffer before sectioning into 50 µm slices with a vibratome. The slices were then 
mounted in 70% glycerol in PBS on glass slides. Slices were imaged at room temperature 
using an Eclipse C1si laser-scanning confocal microscope (Nikon Instruments) equipped 
with a 10x, 0.45 NA, Plan Apo objective and 32 photomultiplier tubes. Alexa Fluor 555 was 
excited at 561 nm. Fluorescence data were collected from 570-730 nm, and images were 
averaged over three scans. Images were unmixed using standard spectra acquired from slices 
of mock-injected cells and Alexa Fluor 555 alone.  
2.5.5 Chemical synthesis and characterization 
2.5.5.1 Materials. Commercial reagents and solvents, purchased from Sigma Aldrich and 
VWR, were used as received. Triethylamine was freshly distilled from CaH2 prior to use. 
Deuterated solvents for NMR experiments were purchased from Cambridge Isotope 
Laboratories and used without further purification. Compounds 1,35 and 4,36 and pdCpA39 
were synthesized as previously reported. Reactions involving air- or moisture-sensitive 
reagents were performed in anhydrous solvents under an atmosphere of Ar. Flash 
chromatography was performed using silica gel from Merck (230-400 mesh). Analytical TLC 
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was performed using plates from Sigma-Aldrich (60 Å pore size, F254, 0.25 mm) and was 
visualized by UV irradiation (254 nm) or staining with potassium permanganate.  
2.5.5.2 Instrumentation. 1H and 13C NMR spectra were obtained using Varian NMR 
instruments. Chemical shifts are reported in parts per million (ppm, δ) referenced to the 
residual 1H resonance of the solvent. 13C NMR spectra were referenced to the residual 13C 
resonance of the solvent. Splitting patterns are designated as follows: s, singlet; br, broad; d, 
doublet; dd, doublet of doublets; t, triplet; q, quartet; m, multiplet. Mass spectroscopic data 
were acquired using an Agilent 1100 Series LC/MSD equipped with an ESI-APCI source. 
HPLC preparative purification was performed using a Waters 1525 binary pump, a Waters 
2996 photodiode array detector, and an Atlantis Prep T3 OBD 5µm 19x150mm column.  
2.5.5.3 Reaction conditions. 
 
(S)-methyl 3-(2-methyl-1H-imidazol-4-yl)-2-(2,2,2-trifluoroacetamido)propanoate (2). 
To a solution of 1 (3.0 g, 11.3 mmol) in a mixture of 0.38 M aqueous sulfuric acid (30 mL, 
11.3 mmol) and glacial acetic acid (30 mL) was added silver nitrate (960 mg, 5.65 mmol) at 
room temperature. The mixture was heated to 80 °C with stirring, and ammonium persulfate 
(12.9 g, 56.5 mmol) was slowly added as a solution in 60 mL of water over 10 minutes via 
cannula. After another 20 minutes, the reaction was poured over 100 g ice and allowed to 
come to room temperature. The mixture was basified with concentrated aqueous ammonium 
hydroxide to pH 10, then extracted with ethyl acetate (3 x 100 mL). The combined organic 
layers were dried over sodium sulfate, then filtered and concentrated. The desired product 
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was partially purified by column chromatography (SiO2, 10% MeOH/DCM) to give 2 as a 
white solid (105 mg, 3%). 1H-NMR (300 MHz; CD3OD) δ:  6.70 (s, 1H), 4.72 (dd, J = 9.5, 
5.0 Hz, 1H), 3.73 (s, 3H), 3.14 (dd, J = 14.9, 5.0 Hz, 1H), 2.97 (dd, J = 14.8, 9.6 Hz, 1H), 
2.32 (s, 3H); 13C NMR (126 MHz; CD3OD) δ: 172.0, 158.8 (q, JF = 37.60), 146.0, 133.9, 117.2 
(q, JF = 286.59), 117.1, 54.2, 53.0, 29.5, 13.3; 19F NMR (282 MHz; CD3OD) δ: -78.9; LRMS 
(ESI) 278.0 [M-H]-. 
 
(S)-3-(1-(((4,5-dimethoxy-2-nitrobenzyl)oxy)carbonyl)-2-methyl-1H-imidazol-4-yl)-2-
((((4,5-dimethoxy-2-nitrobenzyl)oxy)carbonyl)amino)propanoic acid (6). A solution of 
6 N hydrochloric acid (10 mL) was added to a scintillation vial charged with 2 (190 mg, 0.68 
mmol). A stir bar was added, and the solution was heated to 80 °C and stirred overnight. 
The reaction was then cooled to room temperature and concentrated to a brown solid, 
which was dissolved in methanol and concentrated several times to remove residual 
hydrochloric acid. The crude product was then directly dissolved in a mixture of water (6 
mL) and dioxane (6 mL). Sodium carbonate (505 mg, 4.76 mmol) and 6-nitroveratryl 
chloroformate (375 mg, 1.36 mmol) were added in one portion, and the reaction was allowed 
to return to room temperature with stirring for 5 h. The mixture was then concentrated to a 
solid in vacuo, and the residue was suspended in water (50 mL) and acidified to pH ~2 with 
1 N aqueous hydrochloric acid, then extracted with ethyl acetate (5 x 30 mL). The combined 
organic extracts were dried over sodium sulfate, filtered, and concentrated. The residue was 
purified on a plug of silica (2% AcOH/EtOAc) to give (6) as a tan solid (138 mg, 0.21 
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mmol, 34% yield). 1H NMR (400 MHz; d6-DMSO) δ: 7.72 (s, 1H), 7.61 (s, 1H), 7.22 (s, 1H), 
7.17 (s, 1H), 7.10 (s, 1H), 7.02 (d, J = 6.3 Hz, 1H), 5.62 (d, J = 13.2 Hz, 1H), 5.57 (d, J = 
14.0 Hz, 1H), 5.29 (d, J = 15.4 Hz, 1H), 5.23 (d, J = 15.7 Hz, 1H), 3.92 (s, 3H), 3.85-3.95 (m, 
1H), 3.88 (s, 3H), 3.82 (s, 3H), 3.78 (s, 3H), 2.94 (dd, J = 14.8, 2.8 Hz, 1H), 2.71 (dd, J = 
15.2, 8.2 Hz, 1H), 2.45 (s, 3H); 13C NMR (126 MHz; d6-DMSO) δ: 173.3, 155.1, 153.5, 153.3, 
148.6, 148.3, 147.4, 145.9, 139.7, 138.9, 138.6, 128.9, 124.7, 114.0, 111.6, 109.7, 108.2, 107.8, 
65.7, 61.9, 56.4, 56.10, 56.06, 56.0, 54.9, 31.2, 16.2; LRMS (ESI) 646.2 [M-H]-. 
 
(S)-2-((((4,5-dimethoxy-2-nitrobenzyl)oxy)carbonyl)amino)-3-(2-(trifluoromethyl)-1H 
-imidazol-4-yl)propanoic acid (7). Prepared according to the procedure for 6, starting with 
4 (230 mg, 0.87 mg). The crude mixture was purified by precipitation from a hexanes/ethyl 
acetate mixture, giving 7 as a tan solid (202 mg, 0.29 mmol, 33% yield over 2 steps). 1H 
NMR (500 MHz; d6-DMSO) δ: 7.89 (d, J = 8.1 Hz, 1H), 7.69 (s, 1H), 7.13 (s, 1H), 7.08 (s, 
1H), 5.38 (d, J = 15.1 Hz, 1H), 5.31 (d, J = 15.1 Hz, 1H), 4.29 (td, J = 8.8, 4.5 Hz, 1H), 3.87 
(s, 3H), 3.86 (s, 4H), 3.05 (dd, J = 14.7, 3.9 Hz, 1H), 2.93 (dd, J = 14.6, 9.9 Hz, 1H); 13C 
NMR (126 MHz; d6-DMSO) δ: 172.8, 155.5, 153.5, 147.6, 139.0, 133.7 (q, JF = 39.5 Hz), 
128.0, 118.9 (q, JF = 268.3), 110.0, 108.2, 62.3, 56.1, 53.7; 19F NMR (282 MHz; CD3CN) δ: -
64.0; LRMS (ESI) 461.1 [M – H]-. 
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(S)-4,5-dimethoxy-2-nitrobenzyl 4-(3-(cyanomethoxy)-2-((((4,5-dimethoxy-2-nitro-
benzyl)oxy)carbonyl)amino)-3-oxopropyl)-2-methyl-1H-imidazole-1-carboxylate (8). 
To a solution of 6 (80 mg, 0.12 mmol) in a mixture of DMF (1.2 mL) and chloroacetonitrile 
(1.2 mL) was added triethylamine (54 µL, 0.39 mmol). The reaction was stirred for 24 h at 
room temperature, then diluted with ether (10 mL) and washed with water (3 x 10 mL). The 
organic layer was then concentrated to an oil, which was dissolved in ethyl acetate. The 
product was precipitated by addition of hexanes, giving 8 as a tan solid (25 mg, 29%). 1H 
NMR (500 MHz; d6-DMSO) δ: 8.09 (d, J = 7.8, 1H), 7.72 (s, 1H), 7.66 (s, 1H), 7.28 (s, 2H), 
7.11 (s, 1H), 5.64 (s, 2H), 5.35 (d, J = 15.0, 1H), 5.31 (d, J = 14.7, 1H), 5.01 (s, 2H), 4.46-4.42 
(m, 1H), 3.90 (s, 3H), 3.89 (s, 3H), 3.85 (s, 6H), 2.89-2.87 (m, 2H), 2.48 (s, 3H); 13C NMR 
(126 MHz; d6-DMSO) δ: 170.8, 155.5, 153.4, 153.2, 148.5, 148.4, 147.7, 146.8, 140.1, 139.1, 
135.8, 127.6, 124.3, 115.6, 115.5, 112.4, 110.3, 108.3, 108.1, 66.0, 62.7, 56.4, 56.2, 56.11, 
56.06, 53.2, 49.5, 29.1, 16.3; LRMS (ESI) 685.1 [M-H]-. 
 
(S)-cyanomethyl 2-((((4,5-dimethoxy-2-nitrobenzyl)oxy)carbonyl)amino)-3-(2-(tri-
fluoromethyl)-1H-imidazol-4-yl)propanoate (9). Prepared according to the procedure for 
8, starting with 7 (150 mg, 0.32 mmol). Following precipitation, 9 was obtained as a tan solid 
(80 mg, 0.16 mmol, 49% yield). 1H-NMR (300 MHz; CDCl3) δ: 9.71 (s, 1H), 7.73 (s, 1H), 
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7.07 (s, 1H), 7.03 (d, J = 2.0 Hz, 1H), 6.50 (d, J = 8.8 Hz, 1H), 5.63 (d, J = 15.5 Hz, 1H), 
5.49 (d, J = 15.8 Hz, 1H), 4.80 (d, J = 15.7 Hz, 1H), 4.77-4.72 (m, 1H), 4.67 (d, J = 15.7 Hz, 
1H), 3.97 (d, J = 10.3 Hz, 6H), 3.28 (dd, J = 15.1, 4.8 Hz, 1H), 3.16 (dd, J = 14.5, 4.8 Hz, 
1H); 13C-NMR (126 MHz; d6-DMSO) δ: 170.6, 155.5, 153.4, 147.8, 139.2, 137.53, 133.9 (q, JF 
= 38 Hz), 127.5, 118.8 (q, JF = 265 Hz), 117.3, 115.4, 110.3, 108.2, 62.7, 56.09, 56.04, 53.76, 
49.5, 29.3; 19F NMR (282 MHz; CDCl3) δ: -63.7; LRMS (ESI) 500.1 [M – H]-.  
 
(S)-cyanomethyl 2-hydroxy-3-phenylpropanoate (11). Prepared according to the 
procedure for 8, starting with 10 (100 mg, 0.60 mmol). Following precipitation, 11 was 
obtained as a colorless oil (85 mg, 0.41 mmol, 69% yield). 1H NMR (500 MHz; CDCl3) δ: 
7.33-7.30 (m, 2H), 7.28-7.25 (m, 1H), 7.22-7.20 (m, 2H), 4.75 (d, J = 15.7, 1H), 4.72 (d, J = 
15.7, 1H), 4.53 (q, J = 5.6, 1H), 3.14 (dd, J = 14.0, 4.8, 1H), 3.02 (dd, J = 14.0, 6.7, 1H), 2.70 
(d, J = 6.5, 1H); 13C NMR (126 MHz; CDCl3) δ: 172.5, 135.4, 129.5, 128.7, 127.3, 113.7, 71.3, 
48.9, 40.4; LRMS (ESI) 204.0 [M-H]-. 
 
4,5-dimethoxy-2-nitrobenzyl 4-((2S)-3-((5-(((((5-(4-amino-2-oxopyrimidin-1(2H)-yl)-
2-((phosphonooxy)methyl)tetrahydrofuran-3-yl)oxy)(hydroxy)phosphoryl)oxy)- 
methyl)-2-(6-amino-9H-purin-9-yl)-4-hydroxytetrahydrofuran-3-yl)oxy)-2-((((4,5-
dimethoxy-2-nitrobenzyl)oxy)carbonyl)amino)-3-oxopropyl)-2-methyl-1H-imidazole-
1-carboxylate (3). A 0.5-dram vial was charged with 10 mg pdCpA•2.4 TBAH and a stir bar, 
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then evacuated and backfilled several times with argon. A 0.02 M solution of 8 in DMF (0.5 
mL, 0.01 mmol) was then added, and the mixture was stirred under argon overnight. The 
product was then purified using reverse-phase HPLC to give 3 as a white solid. MALDI-MS 
(6-aza-2-thiothymine matrix) 1026.9 [M-NVOC+H]+.  
 
(2S)-5-(((((5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-((phosphonooxy)methyl) 
tetrahydrofuran-3-yl)oxy)(hydroxy)phosphoryl)oxy)methyl)-2-(6-amino-9H-purin-9-
yl)-4-hydroxytetrahydrofuran-3-yl 2-((((4,5-dimethoxy-2-nitrobenzyl)oxy)carbonyl) 
amino)-3-(2-(trifluoromethyl)-1H-imidazol-4-yl)propanoate (5). Prepared according to 
the procedure for 3, starting with 9. MALDI-MS (6-aza-2-thiothymine matrix) 1081.2 
[M+H]+.  
 
(2S)-5-(((((5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-((phosphonooxy)methyl) 
tetrahydrofuran-3-yl)oxy)(hydroxy)phosphoryl)oxy)methyl)-2-(6-amino-9H-purin-9-
yl)-4-hydroxytetrahydrofuran-3-yl 2-hydroxy-3-phenylpropanoate (12). Prepared 
according to the procedure for 3, starting with 11. MALDI-MS (6-aza-2-thiothymine matrix) 
785.4 [M+H]+.  
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Chapter 3: Interrogation of Gating Motions of GLIC via Non-Canonical 
Amino Acid Mutagenesis at Sensitive Prolines* 
3.1 Abstract 
Gloeobacter violaceus ligand-gated ion channel (GLIC) has served as a valuable 
structural and functional model for the eukaryotic Cys-loop receptor superfamily. In Cys-
loop and other receptors, we have previously demonstrated the crucial roles played by 
several conserved prolines. Here we explore the role of prolines in the gating transitions of 
GLIC. As conventional substitutions at some positions resulted in nonfunctional proteins, 
we used in vivo non-canonical amino acid mutagenesis to determine the specific structural 
requirements at these sites. Receptors were expressed heterologously in Xenopus laevis 
oocytes, and whole-cell electrophysiology was used to monitor channel activity. Pro119 in 
the Cys-loop, Pro198 and Pro203 in the M1 helix, and Pro299 in the M4 helix were sensitive 
to substitution, and distinct roles in receptor activity were revealed for each. In the context 
of the available structural data for GLIC, the behaviors of Pro119, Pro203, and Pro299 
mutants are consistent with earlier proline mutagenesis work. However, the Pro198 site 
displays a unique phenotype that gives evidence of the importance of the region surrounding 
this residue for the correct functioning of GLIC. 
3.2 Introduction 
The Cys-loop family of ligand-gated ion channels (LGICs) includes nicotinic 
acetylcholine receptors (nAChRs), serotonin receptors (5-HT3Rs), GABAA receptors 
(GABAARs), and glycine receptors (GlyRs). These receptors are pentameric membrane-
spanning proteins that mediate fast synaptic transmission throughout the nervous system.1,2 
                                                
 
*This chapter is adapted with permission from: Rienzo, M., Rocchi, A.R., Threatt, S.D., Dougherty, D.A., and 
Lummis, S.C.R. Perturbation of Critical Prolines in Gloeobacter violaceus Ligand-Gated Ion Channel (GLIC) 
Supports Conserved Gating Motions Among Cys-Loop Receptors. J. Biol. Chem. 291, 6272-6280 (2016). 
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They are members of a larger family, the pentameric ligand-gated ion channels (pLGICs), all 
of which share a pentameric structure and a similar global layout. Individual subunits contain 
a large extracellular N-terminal domain (ECD) and four transmembrane helices (M1–M4). 
Neurotransmitters generally bind in the ECD, at the interface between two adjacent 
subunits, triggering a conformational change that opens the pore, which is lined by the five 
M2 helices. The transduction of binding information to the pore region is not yet fully 
understood, partly because structural data for this family have lagged behind those for many 
other ion channels. However, relevant data are now becoming available, and recent 
publications describing the high-resolution structures of the first mammalian Cys-loop 
receptors (GABAA, 5-HT3, and glycine receptors) have contributed to our growing 
knowledge.3-5 Nevertheless, obtaining structural data on these proteins is challenging, and 
many in the field have turned to prokaryotic pLGICs6,7 as model systems due to their facile 
expression in heterologous systems and relative ease of crystallization. The most widely used 
pLGICs are those from Erwinia chrysanthemi, now known as Dickeya dadantii (Erwinia ligand-
gated ion channel; ELIC)8 and Gloeobacter violaceus (Gloeobacter ligand-gated ion channel; 
GLIC).9–14 These prokaryotic receptors share the general structure of the Cys-loop receptors, 
but lack the large, variable intracellular domain as well as the cysteines in the eponymous 
Cys-loop. Electrophysiological characterization has revealed that these prokaryotic channels 
also share many functional attributes with the eukaryotic pLGICs, including conductance, 
cation selectivity, sensitivity to similar channel blockers, and comparable effects of pore 
mutations.7,15 Over 40 structures of GLIC have been obtained under various crystallization 
conditions, and they are presumed to represent several different thermodynamic states of the 
receptor. This has allowed for evidence-based predictions of global gating transitions 
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conserved among the pLGICs. GLIC thus offers a testing ground for corroboration of 
functional data from mutant receptors with hypothetical conformational changes.  
Unusual among the pLGICs, GLIC is activated by a decrease in extracellular pH, 
rather than by a small-molecule ligand. The receptor is also unique in having proline residues 
that are not found in eukaryotic pLGICs in a number of locations. Proline is set apart from 
the other amino acids by its limited hydrogen bonding capability, increased steric bulk at the 
backbone nitrogen, and greater propensity to exist in a cis conformation at the backbone 
peptide bond. These features are essential for function in many proteins, including some 
eukaryotic Cys-loop receptors.16–19 Understanding the roles of the proline residues in GLIC 
could allow for elucidation of structural transitions during activation and could help clarify 
whether GLIC is an appropriate model system to understand structure-function 
relationships in vertebrate Cys-loop receptors. Here we have substituted each of the proline 
residues in GLIC with alanine to identify any sensitive sites. Because conventional 
mutagenesis at some positions appears to ablate GLIC expression, trafficking, and/or 
function, we have also implemented the subtler probe of non-canonical amino acid 
mutagenesis, which permits small systematic perturbations to steric and electrostatic 
interactions. We identify several trends that agree with those previously observed in 
corresponding sites of the eukaryotic receptors,17–19 as well as several unusual effects that 
reveal regions important for the activation process.  
3.3 Results 
3.3.1 Conventional mutagenesis identifies four sensitive proline sites  
GLIC contains 18 proline residues, 12 of which are also present in related receptors 
(Figure 3.1). Upon mutation to alanine, 14 sites gave functional receptors with only minor 
decreases in pH50 (Figure 3.2), suggesting that these residues are not critical for channel
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Figure 3.1. Sequence alignment of GLIC and eukaryotic pLGICs. Prolines examined in this study are shown in red. 
Shaded residues are conserved or similar in side-chain character among sequences. The M3/M4 loop of the eukaryotic 
receptors has been removed at *. 
 53 
gating. However, conventional mutations at 3 conserved sites (Pro119, Pro203, and Pro299) 
ablated acid-induced currents, and mutation at Pro198, unique to GLIC, resulted in an 
increased sensitivity to protons (i.e. higher pH50). We therefore proceeded to examine these 
four sites more closely with the aid of non-canonical amino acid analogs.  
3.3.2 The Cys-loop Tyr/Phe-Pro motif shows sensitivity to Pro cis bias and hydrophobicity 
The Cys-loop, a disulfide-containing region at the ECD/TM interface, is a unifying 
trait of the eukaryotic pLGICs and has long been thought to contribute to transduction of 
ligand-binding information to the transmembrane domain.16,23,24 Although GLIC lacks the 
two cysteine residues usually found in this loop, the region is structurally similar to the 
vertebrate receptors. The first proline we identified as essential for function, Pro119, is 
located in this loop, and is a highly conserved feature of the Cys-loop of the eukaryotic 
pLGICs (Figure 3.3A). Notably, this proline is generally flanked by 2 aromatic residues. It is 
Figure 3.2. Prolines sites examined in this study. (A) GLIC subunit structure, indicating proline residues (PDB 3EHZ). 
(B) Conventional mutagenesis of GLIC Pro residues. Substitution with Ala mostly had little or no effect on pH50 values, 
although P119A, P203A, and P299 were nonfunctional, and P198A had increased sensitivity. P6-9A indicates simultaneous 
substitution of prolines at sites 6, 7, 8 and 9 with Ala; individual Ala substitutions at these sites yielded similar pH50 values 
(not shown). Data shown are mean ± SEM, n = 3-4. *pH-induced responses were comparable to uninjected cells. Typical 
maximal responses for WT and all Ala-containing mutants were 20-40 µA, except for P14A, where maximal responses were 
2-5 µA. 
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well established that aromatic residues immediately preceding proline sites preferentially 
stabilize the cis backbone conformation of the proline.17,25 Indeed, the highest-resolution X-
ray crystal structure of GLIC shows this proline in the cis configuration.26 In other pLGIC 
structures, including one of GLIC, this proline is in a trans conformation,4, 8–10 but this is a 
subtle distinction that may be beyond the resolution of some structures. At present, we 
cannot rule out the possibility that both conformers can exist in functional pLGICs, bringing 
up the intriguing possibility that they may be linked to different receptor states. 
Previous studies from our group have investigated the potential of various proline 
residues in membrane receptors to undergo cis-trans isomerization as a step in the process 
of channel gating, including a site homologous to Pro119 in a nAChR.16,17 To determine 
whether such an isomerization at Pro119 might be involved in GLIC gating, we performed 
mutagenesis with a number of canonical and non-canonical amino acids. Our data revealed 
this proline to be highly sensitive, yielding no functional receptors when substituted with 
Ala, Leu, or Gly (Table 3.1). Many prolines serve to disrupt secondary structure, because 
their backbone nitrogen lacks the hydrogen bond-donating site present in the other amino 
acids. To see whether this condition would be sufficient to allow the channel to function, we 
introduced Aah and Lah, the α-hydroxy acid analogs of Ala and Leu (Figure 3.4), which also 
lack a backbone hydrogen bond-donor. Such mutations at Pro sites often produce fully 
functional receptors. However, at Pro119 of GLIC these analogs resulted in no functional 
responses. This is a phenotype that would be expected if interconversion between cis and 
trans forms were required for channel activation because all of these substitutions would 
disfavor isomerization, but it is also consistent with a cis orientation being essential for 
function. Interestingly, two analogs with increased intrinsic cis-biases, the six-membered 
rings Pip and Mor, engendered an increase in sensitivity to acid. This effect was similar to 
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that which was observed in the nAChR (Table 3.1; Figure 3.3B). We considered an 
additional analog, Aze, which is also expected to have an increased cis-bias, but we were 
unable to observe receptor function when we attempted to incorporate Aze.  
In the case of the nAChR, receptor function markedly favored hydrophobicity at 
both the proline and the preceding aromatic residue.17 Introduction of methyl groups on 
either side chain resulted in lower EC50 values than were expected based on the proline cis 
preference, whereas the more polar Mor and flp gave the opposite effect. Although a similar 
Site Mutation pH50 Hill Slope Site Mutation pH50 Hill Slope 
Pro119 Ala NR NR Pro203 Ala NR NR 
 Leu NR NR  Leu NR NR 
 Gly NR NR  Gly NR NR 
 Pro 5.40 ± 0.06 1.6 ± 0.1  Pro 5.61 ± 0.01 1.9 ± 0.1 
 Aah NR NR  Aah NR NR 
 Lah NR NR  Lah NR NR 
 N-MeAla NR NR  N-MeAla 5.24 ± 0.03 1.7 ± 0.1 
 Aze NR NR  Aze NR NR 
 Pip 6.34 ± 0.02 2.1 ± 0.1  Pip NR NR 
 Mor 6.35 ± 0.02 3.1 ± 0.1  Mor 4.73 ± 0.02 2.0 ± 0.1 
 P3mb 6.47 ± 0.01 1.5 ± 0.1  P3mc < 4.5  
 Dhp NR NR  Dhp 5.12 ± 0.04 1.4 ± 0.1 
 Flp 5.58 ± 0.07 1.7 ± 0.2  Flp NR  
 flp NR NR  flp 5.63 ± 0.02 2.0 ± 0.1 
Pro198 Ala 6.70 ± 0.03 0.7 ± 0.1 Pro299 Ala NR  
 Leu 6.37 ± 0.03 2.4 ± 0.2  Leu NR  
 Gly 6.48 ± 0.02 2.4 ± 0.2  Gly NR  
 Pro 5.64 ± 0.02 1.6 ± 0.1  Pro 5.52 ± 0.02 1.6 ± 0.1 
 Aah 5.29 ± 0.02 1.4 ± 0.1  Aah NR  
 Lah 5.33 ± 0.05 1.4 ± 0.1  Lah 5.44 ± 0.02 1.3 ± 0.1 
 N-MeAla 5.33 ± 0.05 1.2 ± 0.1  N-MeAla 5.53 ± 0.05 1.5 ± 0.1 
 Aze 5.88 ± 0.04 1.7 ± 0.1  Aze NR  
 Pip 5.53 ± 0.03 1.2 ± 0.1  Pip 5.77 ± 0.03 1.6 ± 0.1 
 Mor 5.93 ± 0.02 1.7 ± 0.1  Mor 5.75 ± 0.02 1.6 ± 0.1 
 P3m 5.76 ± 0.06 1.2 ± 0.1  P3m 5.60 ± 0.03 1.4 ± 0.1 
 Dhp 5.42 ± 0.03 1.3 ± 0.1  Dhp 5.41 ± 0.04 1.4 ± 0.1 
 Flp 6.10 ± 0.05 1.5 ± 0.1  Flp 6.01 ± 0.02 2.2 ± 0.1 
 flpb 6.52 ± 0.02 1.9 ± 0.2  flp 5.91 ± 0.01 1.6 ± 0.1 
 
Table 3.1. Unnatural proline mutagenesis in GLIC. pH50 values and Hill coefficients of unnatural proline mutations 
examined in this study.a 
 
aData shown are mean ± SEM. NR indicates that acid-induced responses were comparable to those recorded from 
uninjected oocytes. Ala, Leu, and Gly mutants were generated by conventional mutagenesis. All other mutants were 
generated via nonsense suppression.  
bA biphasic curve was observed with a low-sensitivity component having pH50 < 4.5.  
cCurrents were observed, but pH50 was too low to measure (< 4.5), due to nonspecific acid-induced currents.  
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trend was observed with P3m and Flp at the GLIC site, Mor showed nearly the same pH50 as 
Pip. The aromatic residue preceding Pro119 in GLIC is tyrosine, but it is phenylalanine in 
the nAChR and other Cys-loop receptors. We therefore repeated the experiment in 
combination with the Y118F mutation to determine if this difference in polarity could 
account for the altered hydrophobicity effect. In the Y118F background, the Mor- and Pip-
containing mutants still yielded very similar pH50 values (Table 3.2), indicating that other 
factors intrinsic to GLIC must be responsible for the observed phenotype.  
 Flp and flp maintain roughly equivalent steric and polarity contributions, mainly 
varying in the direction of pucker in the cyclic side chain.27 This effect can in turn influence 
the cis-trans equilibrium of the proline, as has been previously shown in a model peptide 
containing a Tyr-Pro motif; Flp, the trans stereoisomer, favors an exo pucker and has a 
strong trans bias (relative to Pro, ΔΔG = –0.56 kcal/mol), while the epimer flp favors an 
endo pucker and a relative cis bias (ΔΔG = 0.35 kcal/mol).28 In contrast to the nAChR, we 
observed currents only from receptors containing Flp, the trans stereoisomer, and not from 
 
 
Figure 3.3. The GLIC YPF motif. (A) The TM/ECD interface in GLIC, highlighting the YPF motif in the cis (PDB 
3EAM). (B) Relationship between mean pH
50 values and cis-trans preferences for Pro analogues at position 119 in GLIC 
(filled circles), compared with the analogous position (Pro136) in the muscle-type nAChR (open squares).17 Typical maximal 
currents for functional mutants generated by nonsense suppression were 0.5-2 µA, with P119Pip giving responses as high 
as 10 µA.   
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flp. Based on the structures showing either cis or trans conformations at this site, the fluoro 
group on Flp is expected to point into the Tyr side chain, whereas the fluoro group on flp 
should point in the opposite direction, toward the subsequent Phe. This suggests a high 
degree of sensitivity not only to the polarity of the side chain, but also to the particular 
orientation and localization of the dipole.  
 A number of the mutations at Pro119 resulted in negligible currents, and so 
disruption of surface expression must also be considered as a possibility, especially for the 
more dramatic conventional mutations. However, as several proline analogs that introduce 
moderate steric perturbations are readily tolerated, it seems most likely that the lack of 
current seen in other cases is due to an effect on gating transitions.  
 
3.3.3 A helical distortion in M1 is involved in activation 
 The second conserved proline that was intolerant to alanine substitution, Pro203, is 
located in the M1 helix. A similar proline is present in all pLGICs, and has been shown to be 
essential for receptor activity in nAChRs and 5-HT3 receptors.18,19 In the Cys-loop receptors 
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this proline displays a distinctive phenotype: conventional mutants give a nonfunctional 
channel, but incorporation of α-hydroxy residues, regardless of side chain, yields robustly 
expressing, ligand-activated receptors. This establishes that of the several unique features of 
a proline residue, lack of a backbone hydrogen bond-donor is the essential requirement here.  
In GLIC, conventional mutants at Pro203 similarly gave negligible current responses. 
Surface expression of the P203L mutant was verified by western blotting of stripped oocyte 
membranes (data not shown), indicating that mutations at this site are capable of rendering 
the receptor nonfunctional, rather than interrupting assembly or trafficking. However, we 
were unable to rescue function by ablation of the backbone NH; α-hydroxy analogs gave 
nonfunctional channels. In fact, Pro203 proved to be extremely sensitive to substitution 
(Table 3.1; Figure 3.5D). Even the very close proline analogs Pip and Aze did not produce 
functional receptors. In contrast, cells injected with N-methylalanine (N-MeAla), which 
ablates the backbone NH but also lacks proline’s cyclic side chain, did yield large currents. 
The substituted proline analogs P3m and flp, as well as the unsaturated Dhp, also gave 
functional channels.  
Mutant pH50 Hill Slope Double Mutant pH50 Hill Slope ΔΔΔGint (kcal/mol) 
wild type 5.50 ± 0.02 1.4 ± 0.1     
S195Sah 5.15 ±0.03 1.7 ± 0.1     
P198L 6.37 ± 0.03 2.4 ± 0.2 S195Sah/P198L 5.76 ± 0.05 1.8 ± 0.1 -0.35 
N199A 4.64 ± 0.02 1.5 ± 0.1 P198L/N199A 6.40 ± 0.02 2.1 ± 0.1 1.21 
N199L 5.21 ± 0.02 1.6 ± 0.1 P198L/N199L 5.98 ± 0.03 2.5 ± 0.1 -0.14 
P119Pip 6.34 ± 0.02 2.1 ± 0.1     
P119Mor 6.35 ± 0.02 3.1 ± 0.1     
Y118F 4.88 ± 0.03 1.9 ± 0.1     
Y118F/P119Pip 5.34 ± 0.04 1.2 ± 0.1 Y118F/P119Morb 5.31 ± 0.04 1.3 ± 0.1 0.19 
 
Table 3.2 Mutant cycle analyses for interactions at the extracellular terminus of M1.a 
aΔΔΔGinteraction was calculated from the formula:  ∆∆∆𝐺interaction = 	−𝑅𝑇ln( ECJK(WT) • ECJK(Mut1,2)ECJK(Mut1) • ECJK(Mut2)) 
where EC50 = 	 10RpH/0 . 
bInteraction energy was calculated using P119Pip, rather than wild type, as a reference point.  
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 This difference in phenotype between GLIC and the eukaryotic Cys-loop receptors 
could be related to a unique feature of the GLIC M1 helix: a second proline, Pro198, located 
a single helix turn away from Pro203. The presence of these two juxtaposed prolines results 
in a more dramatic helix deformation than is normally observed in structures of pLGIC M1 
helices (Figure 3.5A,B). Pro198 mutants generally retained function (Figure 3.5C). Most 
perturbations at Pro198 that preserved proline’s lack of a backbone hydrogen bond-donor 
displayed a pH50 within 0.3 units of the wild type receptor. However, mutations to the 
Figure 3.5. The GLIC M1 prolines. (A and B) Pro198 and Pro203 in the top of the M1 helix at pH 7 (PDB 4NPQ) (A) 
and pH 4 (PDB 3EHZ) (B). Shown are a hydrogen bond between Asn199 and the main-chain carbonyl of Ser195 (black), 
the disrupted hydrogen bond hypothesized to be restored by conventional mutagenesis at Pro198 (red), and the interhelix 
hydrogen bond between His234 and the Ile258 carbonyl (green). (C and D) pH50 values for GLIC Pro198 (C) and Pro203 
(D) mutants. Data shown are mean ± SEM, with n = 8-20. Conventional mutants at Pro198 gave currents comparable with 
wild type GLIC. Typical maximal currents from functional mutants generated by nonsense suppression were 0.5-3 µA, with 
P198Lah giving responses as high as 20 µA. *pH-induced responses comparable to uninjected cells; §a biphasic curve was 
observed with a low-sensitivity component having pH50 < 4.5; ‡currents were observed, but pH50 was too low to measure 
(< 4.5), due to nonspecific acid-induced currents. 
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canonical amino acids Gly, Ala, or Leu resulted in a gain of function (activation at lower acid 
concentrations). These mutants could potentially allow formation of a backbone hydrogen 
bond between the introduced NH and the carbonyl of Phe194, perhaps stabilizing the M1 
helix and favorably influencing the open conformation. To test this hypothesis, we weakened 
the hydrogen bonding ability of the Phe194 carbonyl via incorporation of an a-hydroxy acid 
at the adjacent residue, Ser195. The resulting mutant P198L/S195Sah does indeed show a 
more basic pH50 value than that of the single mutant P198L (Table 3.2). However, 
examination of the S195Sah mutation alone reveals that the effects of the two mutations are 
nearly additive, suggesting that this hydrogen-bonding interaction may not be responsible for 
the observed gain of function in the conventional Pro198 mutants.  
In another effort to examine the importance of hydrogen bonding in this region, we 
mutated Asn199, the side chain of which forms a strong hydrogen bond with the Ser195 
main-chain carbonyl in the crystal structure (Figure 3.5A,B). Although the isosteric N199L 
mutant produced only a minor effect, removal of the bulky side chain in N199A dramatically 
reduced pH50, indicating important steric requirements in the intersubunit region 
immediately surrounding Pro198. Furthermore, introduction of the N199A mutation in the 
presence of P198L results in no change in pH50 compared with the proline mutation alone. 
This suggests that the effects of a conventional mutation at Pro198 obviate the need for 
steric bulk at the side chain of Asn199, pointing to a modified intersubunit interaction as the 
origin of the gain of function.  
3.3.4 The M4 Pro residue 
Recent data have indicated that the M4 helix is a highly important region of pLGICs 
that is involved in allosteric modulation of receptor function via interaction with lipids, the 
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adjacent M1 and M3 helices, and the extracellular domain.29,30 The final sensitive residue 
identified in GLIC, Pro299, is located in the middle of the M4 helix (Figure 3.6A), and has 
recently been identified as functionally important in an alanine screen of the M4 helix.31 
Although a homologous proline does not appear in the nAChRs or 5-HT3Rs, it is conserved 
in the GABAARs, GlyR, and ELIC. In each of the available structures containing a proline in 
this position, a clear and dramatic helix kink is observed. Conventional mutants at this site 
resulted in nonfunctional receptors. In contrast, with the exception of Aah and Aze, most 
analogs lacking a backbone NH rescued function, giving close to wild type characteristics 
(Figure 3.6B). Similar to the behavior typically observed for the M1 proline of Cys-loop 
receptors (but not in the case of GLIC), this pattern indicates that disruption of the helix by 
deletion of a hydrogen bond is sufficient for maintaining the observed kink, and therefore, 
channel function. 
  
 
Figure 3.6. GLIC Pro299. (A) The GLIC TMD, highlighting Pro299 (PDB 3EHZ). (B) pH50 values for GLIC Pro299 
mutants. Data shown are mean ± SEM, with n = 7-20. Typical maximal currents from functional mutants generated by 
nonsense suppression were 0.5.-5 µA. *pH-induced responses comparable with uninjected cells.  
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3.4 Discussion 
Previous studies concerning the functions of conserved prolines in transmembrane 
receptors16-19,32 have given rise to several commonly observed phenotypes: (1) those for 
which cis bias influences activity, (2) those for which ablation of a backbone hydrogen bond 
suffices to produce near wild type function, and (3) those for which steric bulk at the amine 
is necessary. Of the prolines examined above, Pro119 conforms to the first group, Pro299 
conforms to the second, and P203 conforms to the last. Examination of the available GLIC 
structural data also reveals that the conformational effects conferred by these residues are 
consistent with those of previously studied prolines with the same phenotypes: Pro119 is 
located in a potentially flexible loop; Pro299 forms a kink in M4 due to simple ablation of a 
hydrogen bond; P203 exists below a prominent bulge and displays steric requirements we 
have previously reported for a conserved bulge-inducing proline in the D2 dopamine 
receptor.32  
 Although structural information from GLIC in a number of states has been 
obtained, it remains to be determined whether the gating motions observed in GLIC mirror 
the global conformational changes that govern activation of the eukaryotic Cys-loop 
receptors. Despite the lack of the disulfide in the loop containing Pro119, both the structure 
of the loop and the effects of cis bias and hydrophobicity at Pro119 closely resemble what 
we have observed at the analogous site in the nAChR. This supports the notion that during 
activation, any reorganization involving the Tyr/Phe-Pro motif is likely conserved, at least 
between nAChRs and GLIC. In the open GLIC structure (PDB 3EHZ), this loop directly 
contacts the M2-M3 loop via hydrophobic interactions and a cation-π interaction between 
Arg116 and Tyr250 (Figure 3.5B), which suggests that the conformation of the “Cys-loop” 
could be coupled to the gating motions of M2. As pH50 data for Aze could not be obtained, 
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it is difficult to conclude whether cis conformation at this site is required for channel 
function, or whether a cis-trans isomerization is linked to gating transitions. However, 
considering the failure of this site to tolerate residues without an appreciable cis contributor 
and the gain of function observed upon incorporation of several cis-biased analogs, one of 
these possibilities is likely. 
 The M1 proline corresponding to Pro203 in GLIC is conserved throughout the 
pLGIC superfamily, and in two Cys-loop receptors we find a common phenotype: any 
residue that lacks a backbone NH produces an essentially wild type receptor.18,19 In GLIC, 
however, this proline faces somewhat more stringent requirements: the necessity for 
substitution at the backbone nitrogen of Pro203 suggests that the pronounced bulge in M1 
observed in GLIC crystal structures must be enforced for activation to occur. Examination 
of the closed (pH 7) and open (pH 4) crystal structures13,14 has identified a difference in the 
interface between the extracellular end of M1 and the M2-M3 loop of the adjacent subunit. 
In the open structures, the pre-M1 region is tucked under the adjacent M2-M3 loop, with the 
nonconserved Pro249 sandwiched between Phe194 and Gln192. In contrast, the closed 
structure shows Phe194 pointed away from M1 into lipid, while the M2-M3 loop has shifted 
so that Pro249 has moved past Gln192. It is likely that this shifting occurs concurrently with 
or prior to the bend observed in M2 in the open structures. Substitution of Pro203 with 
analogs bearing a hydrogen bond donor may result in a more ordered helical structure at the 
top of M1, eliminating any flexibility that is enabled by the presence of the bulge in the wild 
type receptor. This could prevent the motion of the M2-M3 loop, which may be required to 
initiate the bending of M2 observed in the open state.  
Alternatively, or in addition, perturbation of Pro203 could interfere with the correct 
alignment of a hydrogen bond that we have previously shown to be crucial for stabilization 
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of the open state.33 In that work, we showed that a backbone amide-to-ester substitution at 
Phe259 attenuates the hydrogen bond-accepting ability of the Ile258 carbonyl, and that tight 
steric complementarity makes this entire region highly intolerant to modification. The side 
chain of Phe259 is in van der Waals contact with both Pro198 and Pro203; thus the bulge 
created by Pro203 allows a direct interaction with the M3 helix of the adjacent subunit, 
which may be essential for function. 
 Interestingly, the nearby Pro198 does not seem to be required to maintain this 
disruption in M1, and does not suffice to rescue function when Pro203 is substituted. The 
distinct and robust increase in proton sensitivity conferred by conventional mutation of 
Pro198 lies in stark contrast with the extreme sensitivity of Pro203. Because mutations that 
introduce a backbone NH at Pro198 cause a gain of function, whereas those that maintain 
proline’s lack of a hydrogen bond-donor produce receptors with wild type-like properties, it 
is tempting to argue that the effect we observe is simply due to an increased ordering of the 
N-terminus of M1. However, the nearly additive effects we observed in the mutant cycle 
analysis with S195Sah make it difficult to conclude whether this is the primary cause of the 
shift in activity. The P198L and N199A mutations, on the other hand, are clearly non-
independent. The importance of stabilizing interactions in the intersubunit region near the 
top of M1 has previously been established by structural studies on ethanol potentiation of 
GLIC mutants.34 Restructuring of this region caused by the conventional Pro198 mutations 
could potentially allow for formation of comparable interactions in the absence of ethanol, 
leading to the observed pH sensitivity increase. 
 If the available structures accurately represent the open and resting conformations of 
GLIC, it does not appear that any major changes occur in the conformation or position of 
the M4 helix between these states. However, recent mutagenesis experiments examining the 
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GLIC M4 helix have indicated that interactions of M4 with M1, M3, and the ECD are 
critical for receptor function.31 In that study, mutations of two or more aromatic residues in 
this region at the interface with M1 or M3 resulted in nonfunctional receptors, and so it is 
most likely that elimination of the M4 kink simply prevents the helix from adopting a 
conformation where these crucial interactions can be maintained. It is also possible that the 
correct structure of the GLIC M4 helix is essential for folding and trafficking of receptors, as 
proper folding of M4 is required for cell-surface trafficking in some other pLGICs. Various 
nAChR subunits, for example, have endoplasmic reticulum retention motifs in the pre-M1 
region, which are masked when M4 binds to M1/M3, permitting cell-surface expression.35 
However, these residues are not well conserved in GLIC, and it is unclear whether a similar 
mechanism is operative. 
 
3.5 Conclusions 
We have identified several highly sensitive proline residues in GLIC. We show that 
the gating energetics for GLIC appear to depend significantly on the structure of the YPF 
motif of the “Cys-loop”, similar to what has previously been seen in eukaryotic nAChRs. We 
find that the highly conserved M1 proline maintains its critical role, albeit with a higher level 
of stringency than in the 5-HT3Rs or nAChRs. Both these results help to validate GLIC as a 
relevant homolog in the study of the gating process of the Cys-loop receptors. The M1 and 
M4 sites obey previously observed phenotypes for bulge- and kink-inducing prolines, 
respectively, reinforcing our devised classification strategy. Finally, we highlight the 
importance of stabilizing interactions in the intersubunit space adjoining the extracellular 
terminus of M1 based on unusual effects of substitutions to the Pro198 site. Further studies 
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will be required to delineate the structural consequences of mutations at this position, and 
may illuminate poorly understood aspects of the activation process. 
 
3.6 Experimental procedures 
3.6.1 Molecular biology 
The cDNA for GLIC was in the pGEMhe plasmid. Site-directed mutagenesis was 
performed using the Stratagene QuikChange protocol to generate the appropriate codon. 
For non-canonical amino acid mutants and conventional mutants generated by nonsense 
suppression, the site of interest was mutated to the TAG stop codon. Plasmids were 
linearized with the SbfI restriction enzyme, and receptor mRNA was then prepared by in 
vitro runoff transcription using the Ambion T7 mMessage mMachine kit. 
Hydroxy or amino acid-dCA conjugates were enzymatically ligated to truncated 
74mer THG73 tRNA as previously described.20,21 The 74mer tRNA was prepared using the 
Ambion T7MEGAshortscript kit by transcription from a DNA oligonucleotide template 
modified to enhance RNA transcript homogeneity, as described in the literature.22 Crude 
tRNA-amino acid or tRNA-hydroxy acid product was used without desalting, and the 
product was confirmed by matrix-assisted laser desorption ionization time-of-flight mass 
spectrometry on a 3-hydroxypicolinic acid matrix. Deprotection of the NVOC group on the 
tRNA-amino acids was carried out by photolysis for 5 minutes on a 300-watt high-pressure 
mercury arc lamp with WG-335 and UG-11 filters immediately prior to injection.  
3.6.2 Oocyte preparation and RNA injection 
Stage V-VI oocytes of Xenopus laevis were harvested and injected with RNAs as 
described previously.21 For nonsense suppression experiments, each cell was injected with 
50-100 ng each of receptor mRNA and appropriate tRNA approximately 48 h before 
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recording. Mutants yielding small responses required 72 h of incubation, with a second 
injection of mRNA and tRNA 48 h before recording.  
For wild type experiments and conventional mutants, each cell received a single 
injection of 1-25 ng of receptor mRNA approximately 24 h before recording. Injection 
volumes for each injection session were 50-100 nL per cell.  
As a negative control for suppression experiments at each site, unacylated full-length 
tRNA was co-injected with mRNA in the same manner as charged tRNA. These 
experiments yielded negligible responses for all sites. Wild-type recovery conditions 
(injecting tRNA charged with the appropriate amino acid to regenerate a wild type channel 
via nonsense suppression at a TAG stop codon) were injected alongside mutant nonsense 
suppression conditions as a positive control.  
3.6.3 Electrophysiology 
Oocyte recordings were made in two-electrode voltage clamp mode using the 
OpusXpress 6000A (Axon Instruments). Oocyte equilibration and washes were performed 
with Ca-free ND96 (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES) adjusted to pH 
8 with 1 N NaOH. The pH of buffers for concentration-response curves were adjusted 
accordingly with NaOH or HCl, and buffers with pH below 6.8 contained 5 mM MES in 
place of HEPES. Initial holding potential was -60 mV. Data were sampled at 125 Hz and 
filtered at 50 Hz. Oocytes were equilibrated for 30 s at 1 mL/min before each pH 
application. The pH buffer applications lasted for 15 s at 4 mL/min, followed by a 15-s wait 
period to allow the cells to attain a peak current. Cells were then washed for 40 s at 3 
mL/min before the following equilibration. Concentration-response data were obtained for 
9 buffer pHs, for a minimum of two cell batches, and for a minimum of 7 cells total (or 3-4 
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cells from 1-3 batches for alanine scanning). The concentration-response relations for each 
cell were fitted to the Hill equation: 
 𝐼 𝐴 = $max() [+]EC/0 1H, (Eq. 3.1) 
where Inorm is the normalized current peak at [H3O+] = A, EC50 is the value of [H3O+] that 
elicits a half-maximum response, and nH is the Hill coefficient. The values for each cell were 
then averaged to give the reported values, where pH50 = -log(EC50). At pH < 4, uninjected 
cells gave current responses that were occasionally up to ~ 200 nA. Thus, data were only 
reported from cells that gave responses above pH 4, or that gave larger, more robust 
currents below pH 4, and other cells were considered non-responsive (NR).  
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Chapter 4: Tools for Exploring Acid-Sensing Ion Channel Function* 
4.1 Abstract 
We aim to understand the molecular basis of pH sensing and channel gating in the 
acid-sensing ion channels (ASICs). ASICs are trimeric ion channels found in the central 
nervous systems of chordates, with implications in pain sensation, ischemic stroke, and 
cognitive function. Crystal structures have provided clues to the origins of ion selectivity in 
ASIC1a, and we have tested these models using α-hydroxy analogs of pore-lining amino 
acids. We also use fluorination of an aromatic amino acid to determine molecular factors 
involved in the selectivity of the active component of a tarantula venom, psalmotoxin, for 
ASIC1a over other ASIC subtypes. Based on structural data, ASIC1a is thought to detect pH 
changes by binding protons among several pairs of carboxylic acid residues. We planned to 
investigate these sites using fluorinated variants of glutamate and aspartate, and discuss 
progress toward the syntheses of these probes. 
4.2 Introduction 
ASICs are a class of trimeric, membrane-spanning proteins1 and have been 
implicated in ischemic stroke, pain perception, mechanosensation, learning, and memory.2-5 
These channels are members of the amiloride-sensitive epithelial sodium channel/degenerin 
(ENaC/DEG) family, and are expressed in neurons throughout the central and peripheral 
nervous systems in multicellular eukaryotes.6 ASICs are classified by sequence homology, 
and despite their name, are not all acid-sensitive.7-9 There are four known genes coding for 
ASICs in humans (ASIC1-4), three of which exist in different splice variants.6 The subunits 
can form functional homomeric and heteromeric channels (with the exception of ASIC2b 
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and ASIC4, which are only functional in heteromers with other subunits), which exhibit 
different acid sensitivities, ion selectivities, and desensitization kinetics.10 Homomers and 
heteromers are both formed under native conditions.  
 Several nonspecific inhibitory ligands for ASICs exist, including amiloride, aspirin, 
and ibuprofen. Specific peptide binders of ASICs include psalmotoxin 1 (PcTx1), a 
component of the venom from the Trinidad chevron tarantula that targets ASIC1a 
homomers;11 mambalgins, a class of three-finger peptide toxins from the black mamba that 
target ASIC1a homomers and heteromeric ASIC1a/2a or ASIC1a/2b channels;12 and MitTx, 
the active species in Texas coral snake venom, which shows some selectivity for ASIC1a and 
2a homomers.13 It has been shown that activation of ASIC1a during ischemic stroke plays a 
role in neuronal damage, and treatment of cells with PcTx1 to inhibit the channel has 
demonstrated a neuroprotective effect.14 Thus, understanding the mechanisms by which 
ASIC1a detects extracellular acidosis and is inhibited by peptides like these may lead to 
improved therapies for ischemic stroke and chronic pain.  
 This project focuses first on understanding the function of the homomeric ASIC1a 
channel, due to its physiological interest and the availability of several X-ray crystal 
structures.15-19 ASIC1 is the most abundant gene of its family in the central nervous system.20 
It gives rise to two protein subunits, ASIC1a and ASIC1b, although the latter protein is only 
produced in the peripheral nervous system.21 Although we are primarily interested in 
homomers of ASIC1a, the ASIC1a subunits are also known to form heteromers with 
subunits of other types.22 ASIC1a homomers are the most acid-sensitive of the ASIC 
channels, displaying current responses at pHs as high as 6.9.23 Currents are sharply 
dependent upon pH, with maximum whole-cell responses observed at around pH 6 (Figure 
4.1). The high Hill coefficient of ASIC1a (~5.5) is characteristic of channels that bind a large 
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number of ligands in a cooperative fashion, and has been interpreted as an indication of a 
large number of proton-binding sites in the extracellular domain. Upon prolonged exposure 
to acid, these channels undergo a second conformational change into a non-conducting 
state, called the desensitized state. Channels in this state are not visibly activated by changes 
in pH, and must be incubated at high pH before a macroscopic response can be observed 
again. ASIC1a desensitizes with a time constant of 1-2 s, recovering from desensitization 
after several seconds at elevated pH.  
 This desensitization complicates the thermodynamic model generally used for 
LGICs, since it is unclear whether the channel population reaches an equilibrium between 
the closed and open states before channels begin to desensitize. If no equilibrium is reached, 
the maximum current observed will not necessarily provide accurate thermodynamic 
information about the relative energies of the closed and open states. Instead, it provides a 
kinetic parameter – a quantity proportional to the maximum number of receptors open 
Figure 4.7. Acid-sensitivity of wild type ASIC1a. (A) Representative whole-cell current traces from two-electrode 
voltage clamp of Xenopus laevis oocytes expressing ASIC1a. The top trace shows the observed current upon application of 
decreasing pH buffers, equilibrating with pH 7.8 buffer between test applications. The bottom trace shows the steady-state 
desensitization achieved after equilibrating in decreasing pH buffers, assaying the proportion of activatable channels with 
applications of pH 6 test buffer. (B) Line graph showing the peak current data collected from traces such as those shown in 
(A). Mean normalized currents are plotted from 8-12 cells, with standard errors indicated.  
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during the course of the treatment. In spite of these complications, most reports of ASIC1a 
biophysical properties fit the maximum observed current responses at each pH to the Hill 
equation, assuming a traditional binding model. 
In addition to desensitization following current responses, ASIC1a also exhibits 
desensitization without any observable macroscopic current. In other words, after 
equilibration at pHs below 7.4, treatment with pH 6 buffer triggers a diminished current 
response.20,21 This has been termed steady-state desensitization (SSD), and can also be fit to a 
Hill function. There is evidence supporting a model in which channels proceed through the 
open state to the desensitized state, wherein the accumulation of open channels is small 
enough that currents are invisible to a whole-cell voltage clamp. Namely, mutations that shift 
the EC50 of ASIC1a also often have comparable effects on the SSD curve.23 However, 
treatment of ASIC1a with mambalgin-1 appears to cause inhibition of acid-induced currents 
without influencing the SSD curve, suggesting that SSD may indeed occur by an 
independent pathway, perhaps without involving any open state.12  
  Members of the ENaC/DEG family share a common general structure (Figure 1.3). 
Each subunit comprises two transmembrane helical domains linked by a large extracellular 
region, with short intracellular N- and C-termini.24 Overall, each ASIC subunit is 
approximately 450 amino acids in length. There are several crystal structures of chicken 
ASIC1a truncations available, both at high and low pH, including several with peptide toxins 
bound.15-19 The three subunits are arranged about the pore with 3-fold symmetry. Each 
subunit resembles an upright forearm and fist, with the extracellular domain connected to 
the transmembrane helices at the base of a large b-sheet domain. Intersubunit contacts are 
formed primarily between the palm and thumb domains. At this interface are located several 
acidic residues expected to be titrated by diminished pH, providing a pH-sensing mechanism 
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for the receptor. A number of highly conserved disulfide linkages give structural stability to 
the thumb domain, which is thought to play a role in conveying conformational changes 
from these proton binding sites to the transmembrane helices.15 A constriction in the 
transmembrane domain in the low-pH structures has been suggested to form the occlusion 
that prevents ion permeation in the desensitized state. Three lateral openings provide access 
to the central pore just above a cavity in the extracellular region along the central axis.16  
Numerous mutagenesis experiments have been used to identify important structural 
features of ASICs and uncover their roles in the mechanism of action of these channels. In 
this chapter, we discuss our efforts to approach the same problem, but using the more subtle 
probes made available by non-canonical amino acid mutagenesis. 
4.3 Results and discussion 
4.3.1 Exploring the origins of sodium selectivity* 
ASICs and ENaCs are both sodium-selective, with GNa/GK ~ 13 and 100-500, 
respectively.25 Prior to the first structural elucidation of ASICs, mutagenesis studies revealed 
that a transmembrane GAS motif highly conserved in Na-selective channels is crucial for 
maintaining this discrimination.6 At the time we performed the studies described here, the 
available crystal structures of ASIC1a (PDB 3HGC, 3IJ4) explained little about the function 
of these residues, as they appear to be positioned at the side of the helix facing away from 
the channel pore.15,16 However, later structures of ASIC1a bound to Texas coral snake toxin, 
MitTx, revealed an unusual structural motif in the transmembrane domain that was not 
previously noticed by the authors: the C-terminal helix of each subunit is discontinuous, with 
the intracellular third positioned at the base of the helix of the adjacent subunit (Figure 
4.2A).19 The GAS motif connects these two portions of the helix, creating a ring around the 
channel pore. This unique feature is now believed to allow ENaC/DEG channels to attain 
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high sodium selectivity, despite having only three transmembrane helices lining the pore. 
Though the studies in this section were designed before its discovery, our interpretation will 
assume this ring to be included in the physiologically relevant protein conformation. 
 A strategy often employed by channels to conduct ions across the membrane 
involves positioning negative charge density in an ordered fashion along the pore. The 
selectivity filter generally functions by providing an ion coordination site that selectively 
stabilizes desired cations using the appropriate number, strength, and arrangement of 
coordinating ligands.25 Lewis basic backbone carbonyl groups often satisfy the role of 
coordinating ligand. To investigate the importance of Lewis basicity in the selectivity filter, 
Figure 4.8. The ASIC1a selectivity filter. (A) Cartoon representation of the ASIC1a transmembrane domain, showing the 
discontinuous M2 helix from each subunit (PDB 4NTY). (B) Effects on ion selectivity from incorporation of α-hydroxy 
acids in the pore-lining region. Currents are normalized to the peak current at pH 6 in the presence of 96 mM Na+ (ND96). 
Mean currents from 3-7 oocytes are plotted with standard errors indicated. ‡Currents were too small to reliably determine 
the relative permeability of potassium. (C) Side view of the transmembrane domain, highlighting residues predicted to be 
involved in ion coordination and sodium selectivity. A structurally important hydrogen bond perturbed by the I446Iah 
mutation is highlighted. (D) View of the selectivity filter from the cytoplasmic end of the pore. The two sets of glycine 
carbonyls thought to coordinate ions at this site are indicated. 
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we used non-canonical amino acid mutagenesis to target backbone carbonyls at four 
positions: the three residues composing the GAS motif (Gly443, Ala444, and Ser445) and 
Gly439, which coordinates cesium in some structures. Our group has commonly  
incorporated α-hydroxy analogs of amino acids as a subtle way of modulating the hydrogen 
bonding ability of backbone carbonyls in receptors.26-30 Because an ester carbonyl is a weaker 
Lewis base than an amide carbonyl, we anticipated that such a substitution at residue i would 
impact ion selectivity if the carbonyl at position i-1 were involved in coordinating ions at the 
selectivity filter. Therefore, the four sites we selected for incorporation were Leu440, Ala444, 
Ser445, and Ile446. 
 In each ion selectivity experiment, receptors were expressed in Xenopus laevis oocytes, 
incorporating the α-hydroxy acid at the site of interest. The channels in each oocyte were 
then equilibrated in standard recording solution (96 mM Na+), and subsequently activated in 
a pH 6 buffer. This procedure was repeated, except in buffers replacing all other cations with 
the cation of interest (Li+ or K+), as described in earlier studies.31,32 Relative conductivities of 
these cations were then compared with sodium.  
In the context of the structures available at the time, these results were somewhat 
unexpected (Figure 4.2B). Two of the substitutions in the GAS motif reduced selectivity, 
increasing the relative permeabilities of K+ and Li+. This observation reinforced the 
importance of these residues as the selectivity filter, but the affected carbonyl groups did not 
appear to point toward the channel pore.15,16 For the A444Aah substitution, which should 
have affected the Gly443 carbonyl, currents were too low to obtain reliable values for 
GK+/GNa+, but the relative lithium permeability was maintained in comparison with wild type 
ASIC1a. The Leu440 substitution, which we expected to reduce selectivity by influencing the 
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Lewis basicity of the Gly439 carbonyl, had a minimal effect, only slightly increasing the 
permeability of lithium. 
These data are somewhat more consistent with the recent structures that include 
what is likely to be the true positioning of the GAS motif (Figure 4.2C,D). The I446Iah 
mutation eliminates a hydrogen bonding interaction with the carbonyl of Leu440 that helps 
maintain the conformation of the selectivity filter. This likely results in suboptimal 
positioning of the GAS ring, which would disrupt selectivity for sodium.  
The Lewis basicity of the backbone carbonyl at Ala444, which points into the 
channel pore near the level of an observed Cs+ ion, is weakened by an S445Sah mutation. 
The observed increases in the permeabilities of both Li+ and K+ accompanying this 
substitution are consistent with an important role for the Ala444 carbonyl in preferentially 
stabilizing Na+. However, the effect could also be explained by disruption of what may be a 
structurally important hydrogen bonding interaction between the backbone N-H of Ser445 
and the side chain of Thr448 (N-O distance 3.1 Å).  
In contrast, neither of the backbone mutations influencing Lewis basicities of 
Gly443 or Gly439 backbone carbonyls appeared to impact ion selectivity (although surface 
expression levels were too low to observe K+ currents). These two sets of carbonyls were 
proposed to be the primary coordinating groups in the selectivity filter.19 Our observations 
may indicate that this is not the case; however, it is also possible that preferential 
stabilization of Na+ is largely contingent on the positioning of the coordinating groups, but 
somewhat independent of their Lewis basicities.  
Together with the available structures, these data support critical structural roles for 
the backbone amides of Ile446 and possibly Ser445, as well as potential involvement of the 
backbone carbonyl at Ala444 in ion selectivity. However, these data are preliminary, having 
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been performed on only one batch of oocytes, and will need to be reproduced before final 
conclusions may be drawn. 
4.3.2 A noncovalent interaction with Phe351 influences psalmotoxin selectivity for ASIC1* 
Peptide and protein inhibitors of ASICs offer potential routes for the development 
of pain and stroke therapies, as well as probes for understanding the fundamental 
mechanism of action of the receptors. Here, we have examined the interaction of ASIC1a 
with psalmotoxin (PcTx1), the active component of the venom from Psalmopoeus cambridgei, 
Figure 4.9. The binding interaction between PcTx1 and ASIC1a. (A) Structure of PcTx1. Disulfide bridges are 
highlighted in yellow. Cationic residues residues are shown as sticks (PDB 4FZ0). (B) Electrostatic interactions between 
cationic residues on PcTx1 and anionic side chains in the ASIC1a acid pocket. (C) Aromatic-aromatic interactions involving 
Phe351 and two trypophan residues on PcTx1 thought to be involved in toxin selectivity for ASIC1a. (D) Effects of 
fluorinating Phe351 on current responses in the presence of PcTx1. Mean normalized currents from 5 oocytes are plotted, 
with standard errors indicated. 
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the Trinidad chevron tarantula (Figure 4.3A). PcTx1 is an inhibitor cysteine knot protein, 
about 40 amino acids in length, and containing three disulfide linkages. There are several 
available X-ray structures of PcTx1 in complex with ASIC1a, in which it appears that a 
cluster of cationic residues reach into the electrostatically negative interface between subunits 
to make contacts with anionic and aromatic side chains at the extracellular subunit 
interface.17,18 This interaction apparently increases the affinity of the receptor for protons, 
allowing it to enter the desensitized state at pH ~7.5, resulting in an inactive receptor under 
physiological conditions.11   
 PcTx1 specifically influences the function of ASIC1. Prior to the aforementioned 
structural studies, sequence alignments between ASIC1 and ASIC2 led a different group to 
investigate the specific amino acids that confer this selectivity. Mutagenesis of Phe351 to 
leucine (which replaces Phe351 in ASIC2) significantly reduced the pH50 of ASIC1a (~6.2) 
and ablated any effect of PcTx1 on the channel’s activation curve.33 This observation, along 
with the large number of cationic residues present in PcTx1, suggested that a cation-π 
interaction could potentially be responsible for determining the selectivity of the toxin for 
ASIC1. We therefore proceeded by using nonsense suppression to substitute Phe351 with a 
fluorinated phenylalanine analog, a strategy that we have frequently used to investigate the 
energetic importance of electrostatic aromatic interactions.34-36 
 In this experiment, we used 3,4,5-trifluorophenylalanine (F3Phe), an analog that 
should have a dramatically reduced electrostatic potential at the center of the aromatic ring. 
In the absence of PcTx1, the F351(F3Phe) mutant gave dose-response curves that were very 
similar to those of the wild type receptor (pH50 ~ 6.4).  We then expressed wild type ASIC1a 
and the F351(F3Phe) mutant in Xenopus laevis oocytes, and then used the two-electrode 
voltage clamp to monitor peak whole-cell currents under a number of different conditions. 
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For each oocyte, we normalized responses to the current observed upon application of pH 6 
buffer. Then each cell was treated with buffer at pH 6.75, which gave negligible responses, 
followed by coapplication of pH 6.75 buffer along with two concentrations of PcTx1 
(Figure 4.3D).  
As shown by these responses, both receptors increase in their acid sensitivity at pH 
6.75 when PcTx1 concentration increases, implying that fluorination of Phe351 does not 
completely ablate the ability of PcTx1 to bind or modulate function. The extent to which 
PcTx1 sensitized the wild type receptor was consistently greater than the effect observed on 
the mutant, indicating that an electrostatic attraction at Phe351 is likely an important factor 
for binding selectivity.   
 The structures showing PcTx1 bound to ASIC1a do indeed suggest that Phe351 is 
involved in binding interactions with the toxin.17,18 Rather than a cation-π interaction, two 
edge-face interactions with Trp7 and Trp24 appear to help anchor PcTx1 in place, along 
with numerous other Coulombic interactions between toxin arginine residues and receptor 
aspartic or glutamic acid residues at the subunit interface (Figure 4.3B,C). 
Our data are again only preliminary, conducted on a single batch of cells. A more 
rigorous analysis of the interaction would involve creation of a Schild plot showing the 
relationship between the concentration of toxin and the magnitude of shift in the steady-
state desensitization curve. However, due to the cost of the toxin and the availability of 
detailed structural data on the interaction, we opted not to quantitatively characterize the 
effect or pursue studying the interaction further.  
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4.3.3 Efforts toward probing titratable residues with fluorinated glutamate and aspartate analogs 
The ASIC1a structure reveals a clustering of anionic residues at the extracellular 
subunit interface, dubbed the “acid pocket.”15 This pocket is situated between the thumb 
and finger of one subunit and the palm of the neighboring subunit. Aspartic and glutamic 
acid residues are usually found deprotonated at physiological pH, resulting in anionic side 
chains that can participate in salt bridges and contribute to protein structural stability. 
However, the proximity of several pairs of acidic side chains in this structure (~3-4 Å) 
suggests that at least one of the carboxylates in each pair must be protonated, mediating 
association via a hydrogen bond (Figure 4.4). Indeed, it is well documented that small 
molecules containing proximal carboxylic acids can demonstrate significant shifts in pKa, 
which could enable titration of these pairs at pH ~6.5 in the protein microenvironment.37   
In the first structural study, the authors proposed that the carboxylic acids may 
individually coordinate calcium in the resting state, then dimerize in a cooperative fashion as 
they are protonated and the receptor undergoes a conformational shift into the open state.15 
This hypothesis was tested by a number of studies in which mutation of these residues 
modulates the proton sensitivity of the receptor.38 However, most of these mutations are 
Figure 10.4. The ASIC1a acid pocket. Shown are several carboxylic acid residues that have been proposed as putative 
proton binding sites that are titrated during receptor activation (PDB 2QTS).  
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fairly dramatic, removing the negative charge from the side chain entirely. We sought to 
develop amino acid analogs with quantifiable shifts in acidity. Ideally, these analogs would 
minimally perturb the steric parameters of aspartic or glutamic acid. Such subtle control over 
electrostatics could be useful not only in building a model for the activation of ASICs, but 
also for tweaking reactivity in metalloprotein active sites or exploring factors governing 
protein-protein interactions, such as PcTx1 binding.  
Analogous to our strategy for perturbing aromatic side chains, we chose to attempt 
incorporation of (2S,3S)-3-fluoroaspartic acid (3, FAsp) and (2S,4R)-4-fluoroglutamic acid 
(11, FGlu), due to the known shifts in the pKa values caused by α-fluorination of 
carboxylates,39 the small difference between the atomic radii of hydrogen and fluorine, and 
the relative accessibility of these stereoisomers.40,41 After synthesizing the free amino acids, 
they must be appropriately derivatized for attachment to suppressor tRNAs. This sequence 
is particularly challenging for amino acids with carboxylic acid side chains, since the 
backbone carboxylic acid must be selectively activated for coupling with the pdCpA 
dinucleotide (abbreviated here as dCA. See Chapter 1 for more details on chemical tRNA 
acylation and nonsense suppression). We therefore chose to selectively derivatize the side 
chain carboxylate with a photocleavable protecting group, allowing activation of the 
backbone carboxylic acid as a cyanomethyl ester, as previously described.42 
Our strategy is illustrated in Figure 4.5 and Figure 4.6. In each case, we prepared 
the free amino acid as described by the literature precedent40,41,43 and then protected the 
backbone amine under standard conditions by reacting it with nitroveratryl chloroformate 
for ease of handling and to slow hydrolysis from the tRNA during storage. At this stage, we 
chose to condense the two carboxylic acids into a cyclic anhydride, which could then be 
opened via nucleophilic attack with an alcohol, masking one carboxylate as an ester. We 
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hoped that selective nucleophilic attack with nitroveratryl alcohol on the carbonyl closest to 
the fluoro substituent would enable us to preferentially form a side chain ester, leaving the 
backbone carboxylate free for activation. Prior to injection into oocytes, both the 
nitroveratryl ester and the backbone carbamate would then be photochemically cleaved. 
We began by optimizing the anhydride formation and alcoholysis steps on FAsp. 
After trying a number of dehydration reagents, including phosphorus trichloride, oxallyl 
chloride, thionyl chloride, and acetic anhydride, we determined that stirring a suspension of 4 
in neat acetyl chloride gave fairly clean conversion to anhydride 5a in under 5 hours, along 
with a minor product (5b, <10%) that appears to result from elimination of hydrofluoric 
acid. After treatment of the anhydride with nitroveratryl alcohol for 16 hours, we were able 
to isolate a product with the expected mass of acid 6, although in about equal proportion to 
the elimination product 5b. Analysis by HMBC revealed long-range couplings that 
confirmed the product as having the desired connectivity. We were able to proceed with this 
material, activating the carboxylic acid as a cyanomethyl ester (7). Isolation of 7 was 
Figure 4.11. Attempted synthesis of photocaged dCA-FAsp. Elimination of hydrofluoric acid under dCA coupling 
conditions prevented access to the desired product. 
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nontrivial; as we were concerned about the potential for elimination of hydrogen fluoride, 
we submitted the partially purified product to dCA coupling conditions. However, upon 
HPLC purification of the product mixture, we were only able to assign masses 
corresponding to elimination product 8b.  
Considering the previously observed elimination products, it is no surprise that the 
basic conditions of the dCA coupling reaction resulted in decomposition. It is possible that 
further optimization of these conditions could allow for the intact amino acid to be coupled 
to dCA. However, the reactivity of the amino acid side chain could easily cause 
decomposition during the tRNA ligation or at any time after injection into the oocyte 
cytoplasm. As it is difficult to assess the quality of the amino acid after it has been coupled 
to a biomacromolecule, we decided not to continue work with this analog.  
We expect that the reactivity of FAsp is due to the formation of a large conjugated π-
system upon elimination of hydrofluoric acid, making decomposition highly favorable. Since 
a similar elimination from FGlu would generate a smaller π-system, we were hopeful that it 
would serve as a more stable probe. Unfortunately, due to several low-yielding steps in the 
synthesis of FGlu, we were only able to access a very small mass of diacid 12a. In an effort 
to assess the viability of our route, we opted to make use of a commercially available mixture 
Figure 4.12. Attempted synthesis of photocaged dCA-FGlu. Although significant elimination was not observed, the 
overall synthetic route was prohibitively long and low-yielding.  
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of stereoisomers of 4-fluoroglutamic acid, which we were similarly able to protect as a 
nitroveratryl carbamate (12x). We then used acetyl chloride to effect intramolecular 
condensation into a mixture of anhydrides (13x). Notably, no significant elimination product 
was observed. Treatment of the resulting crude mass with nitroveratryl alcohol, 
dimethylaminopyridine, and triethylamine yielded a new mixture of compounds, including 
some with masses corresponding to the desired monoacid product (14x). However, due to 
the very low crude yield and the complexity of the NMR obtained from the diastereomeric 
mixture, we were unable to determine the regioselectivity of the alcoholysis reaction. 
Despite our failure to incorporate these fluorinated probes, these synthetic efforts 
have yielded a potentially general strategy for regioselectively protecting amino acids with 
carboxylic acid side chains. It is likely that such regioselectivity is limited to cases where the 
electrophilicity of the side chain carboxylate is activated by an electron-withdrawing group at 
the α-position, since alcoholysis of anhydrides derived from the parent amino acids is usually 
selective for the backbone position.44 Further studies will be required to determine the scope 
of this selectivity and the overall utility of the strategy for the purposes of chemical tRNA 
acylation with other glutamic and aspartic acid analogs.  
4.4 Conclusions 
To our knowledge, these studies represent the first applications of the nonsense 
suppression methodology to the investigation of the acid-sensing ion channels. In the 
context of new structural data, the ion selectivity experiments bring up interesting questions 
as to which backbone carbonyl groups are involved in cation stabilization at the selectivity 
filter. Future computational modeling studies could resolve whether the reductions in Lewis 
basicity that we introduce via backbone ester mutations would be expected to influence 
selectivity in a significant way.  
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We have shown that Phe351 is likely to play a role in the selectivity of PcTx1 activity 
on ASIC1a via noncovalent aromatic-aromatic interactions. Although there are clearly 
countless other important electrostatic interactions at the binding interface, it is a testament 
to the power of non-canonical amino acid mutagenesis that such a complex association can 
be energetically probed through such a subtle perturbation. 
Finally, our unsuccessful efforts to incorporate FAsp are an indication that 
introduction of strongly electronegative groups at the 3-position of aspartic acid is likely to 
lead to decomposition. Before additional work is committed to protection and activation of 
a non-canonical amino acid analog containing a functionalized side chain, it is advised that 
the limits of its stability are vigorously tested. Apart from this caveat, it is likely that 
anhydride alcoholysis is a generalizable strategy for producing activated amino acids 
protected by photocleavable groups. 
 
4.5 Experimental procedures 
4.5.1 Molecular biology 
pCR2.1-hASIC1 was a gift from Cecilia Canessa (Addgene plasmid # 32790). The 
region containing the ASIC1a gene was amplified by PCR using primers with overhangs 
containing 5’ HindIII and 3’ XhoI restriction sites. These restriction enzymes were then used 
to subclone the gene into the pGEMhe vector for expression in Xenopus laevis oocytes. Site-
directed mutagenesis was performed using the Stratagene QuikChange protocol to generate 
the appropriate codon. For non-canonical amino acid mutants and conventional mutants 
generated by nonsense suppression, the site of interest was mutated to the TAG stop codon. 
Plasmids were linearized with the SbfI restriction enzyme, and receptor mRNA was then 
prepared by in vitro runoff transcription using the Ambion T7 mMessage mMachine kit. 
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Hydroxy or amino acid-dCA conjugates were enzymatically ligated to truncated 
74mer THG73 tRNA as previously described.27,45 The 74mer tRNA was prepared using the 
Ambion T7MEGAshortscript kit by transcription from a DNA oligonucleotide template 
modified to enhance RNA transcript homogeneity, as described in the literature.46 Crude 
tRNA-amino acid or tRNA-hydroxy acid product was used without desalting, and the 
product was confirmed by matrix-assisted laser desorption ionization time-of-flight mass 
spectrometry on a 3-hydroxypicolinic acid matrix. Deprotection of the NVOC groups on the 
tRNA-amino acids was carried out by photolysis for 5 minutes on a 300-watt high-pressure 
mercury arc lamp with WG-335 and UG-11 filters immediately prior to injection.  
PcTx1 was purchased as a lyophilized powder from Peptide Institute, Inc. The toxin 
was dissolved in Millipore water to a stock concentration of 0.1 mM, and then stored at -80 
°C until use.  
4.5.2 Oocyte preparation and RNA injection 
Stage V-VI oocytes of Xenopus laevis were harvested and injected with RNAs as 
described previously.45 For nonsense suppression experiments, each cell was injected with 1 -
5  ng of mRNA and 20 ng of appropriate tRNA approximately 24 h before recording.  
For wild type experiments and conventional mutants, each cell received a single 
injection of 0.05-0.5 ng of ASIC1a mRNA approximately 18 h before recording. Injection 
volumes for each injection session were 50 nL per cell.  
As a negative control for suppression experiments at each site, unacylated full-length 
tRNA was co-injected with mRNA in the same manner as charged tRNA. Wild-type 
recovery conditions (injecting tRNA charged with the appropriate amino acid to regenerate a 
wild type channel via nonsense suppression at a TAG stop codon) were injected alongside 
mutant nonsense suppression conditions as a positive control.  
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4.5.3 Electrophysiology 
Oocyte recordings were made in two-electrode voltage clamp mode using the 
OpusXpress 6000A (Axon Instruments). Unless otherwise noted, oocyte equilibration and 
washes were performed with ND96 (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 
5 mM HEPES) adjusted to pH 7.8 with 1 N NaOH. The pH of buffers for concentration-
response curves were adjusted accordingly with NaOH or HCl, and buffers with pH below 
6.8 contained 5 mM MES in place of HEPES. Initial holding potential was -60 mV. Data 
were sampled at 125 Hz and filtered at 50 Hz. Oocytes were equilibrated for 30 s at 1 
mL/min before each pH application. The pH buffer applications lasted for 15 s at 4 
mL/min. Cells were then washed for 2 min at 3 mL/min before the subsequent 
equilibration. For concentration-response experiments, responses from each cell were 
normalized to the maximum response observed from that cell, and the normalized currents 
were then averaged. 
4.5.4 Chemical synthesis and characterization 
4.5.4.1 Materials. Unless otherwise specified, all reactions were performed under an argon 
atmosphere in a flame-dried round-bottom flask sealed with a rubber septum, and in freshly 
dried solvents. Air- and moisture-sensitive liquids were transferred using stainless steel 
needles or cannulae. Commercial reagents and solvents, purchased from Sigma Aldrich and 
VWR, were used as received. Triethylamine was freshly distilled from CaH2 prior to use. 
Deuterated solvents for NMR experiments were purchased from Cambridge Isotope 
Laboratories and used without further purification. Compounds 243 and 10,40  as well as 
pdCpA47 were synthesized as previously reported. Flash chromatography was performed 
using silica gel from Merck (230-400 mesh). Analytical TLC was performed using plates 
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from Sigma-Aldrich (60 Å pore size, F254, 0.25 mm) and was visualized by UV irradiation 
(254 nm) or staining with potassium permanganate.  
4.5.4.2 Instrumentation. 1H and 13C NMR spectra were obtained using Varian NMR 
instruments. Chemical shifts are reported in parts per million (ppm, δ) referenced to the 
residual 1H resonance of the solvent. 13C NMR spectra were referenced to the residual 13C 
resonance of the solvent. Splitting patterns are designated as follows: s, singlet; br, broad; d, 
doublet; dd, doublet of doublets; t, triplet; q, quartet; m, multiplet. Mass spectroscopic data 
were acquired using an Agilent 1100 Series LC/MSD equipped with an ESI-APCI source. 
HPLC preparative purification was performed using a Waters 1525 binary pump, a Waters 
2996 photodiode array detector, and an Atlantis Prep T3 OBD 5µm 19x150mm column. 
4.5.4.3 Reaction conditions. 
 
(1R,2R)-1,2-dicarboxy-2-fluoroethan-1-aminium chloride (3). Diester 2 (800 mg) was 
dissolved in an aqueous 5 N solution of hydrochloric acid (30 mL) in a 100-mL round 
bottom flask fitted with a reflux condenser. The mixture was heated to 80 °C and stirred 
overnight. The solvent and hydrochloric acid were then removed by concentration in vacuo, 
followed by iterative dissolution and lyophilization from Millipore water. The resulting crude 
white solid (198 mg) was carried on without further purification.  
EtO2C CO2Et
F
NH2
HO2C CO2H
F
NH3+ Cl-
2 3
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(2R,3R)-2-((((4,5-dimethoxy-2-nitrobenzyl)oxy)carbonyl)amino)-3-fluorosuccinic 
acid (4). Crude amino acid hydrochloride 3 (198 mg) was dissolved in water (30 mL) and 
dioxane (30 mL). Sodium carbonate (694 mg) was added as a solid in one portion, followed 
by 6-nitroveratryl chloroformate (360 mg). The resulting mixture was stirred for 48 h under 
an argon atmosphere. The reaction mixture was then washed with ethyl acetate (3 x 50 mL) 
to remove residual 6-nitroveratryl chloride. The aqueous layer was then cooled in an ice-
water bath and acidified to a pH of 2 by slow addition of 6 N aqueous HCl. At this time, the 
aqueous solution was quickly extracted with ethyl acetate (3 x 100 mL) until no UV-active 
material was observable by TLC in the aqueous layer. The combined organic fractions were 
then dried over anhydrous sodium sulfate, filtered, and concentrated to give a yellow-orange 
residue. This residue was triturated with diethyl ether and dried in vacuo to give 4 as a tan 
solid (96 mg, 16% yield over 2 steps). 1H NMR (300 MHz; CD3CN) δ: 10.01 (s, br, 1H), 
7.74 (s, 1H), 7.18 (s, 1H), 6.57 (d, br, J = 9.0, 1H), 5.49 (s, 2H), 5.34 (dd, JF = 47.0, JH = 2.5, 
1H), 4.99 (ddd, JF = 27.1, JH = 8.7, 2.3, 1H), 3.97 (s, 3H), 3.91 (s, 3H); LRMS (ESI) 389.0 
[M-H]-. 
 
4,5-dimethoxy-2-nitrobenzyl ((3R,4R)-4-fluoro-2,5-dioxotetrahydrofuran-3- 
yl)carbamate (5a). Under air, diacid 4 (30 mg) was added to a 2-dram scintillation vial 
equipped with a stir bar and suspended in acetyl chloride (1.5 mL). The vial was fitted with a 
HO2C CO2H
F
NH3+ Cl-
HO2C CO2H
F
NH
NVOC
3 4
HO2C CO2H
F
NH
NVOC
O
O
O
NH
F
NVOC
4 5a
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rubber septum vented through an oil bubbler, and the suspension was heated to 45 °C with 
stirring. After 2 hours, or when the mixture appears homogenous, the reaction progress was 
assessed by NMR. Upon complete consumption of the diacid, the reaction was returned to 
room temperature and the solvent removed in vacuo. Iterative suspension in anhydrous 
benzene and evaporation in vacuo gave anhydride 5a as a crude tan solid (27 mg), which was 
carried on without further purification. LRMS (ESI) 353.0 [M-H]-. 
 
(2R,3R)-4-((4,5-dimethoxy-2-nitrobenzyl)oxy)-2-((((4,5-dimethoxy-2-
nitrobenzyl)oxy)carbonyl)amino)-3-fluoro-4-oxobutanoic acid (6). A flame-dried 2-
dram vial equipped with a stir bar was charged with crude anhydride 5a (27 mg) and 6-
nitroveratryl alcohol (82 mg) under argon. Freshly distilled ethyl acetate (2 mL) was added by 
syringe, and the reaction was heated to 65 °C with vigorous stirring for 16 h. The solvent 
was then removed in vacuo, and the resulting residue was purified on a short plug of silica 
gel (EtOAc to elute residual alcohol and anhydride, followed by 2% AcOH/EtOAc to elute 
monoacid product) to yield 6 as an orange solid with some small impurities (12 mg, 17% 
yield over 2 steps). HSQC and HMBC were used to assign the reaction regioselectivity. 1H 
NMR (600 MHz; CD3CN) δ: 7.71 (s, 1H), 7.70 (s, 1H), 7.17 (s, 1H), 7.14 (s, 1H), 6.58 (d, J = 
8.2, 1H), 5.57 (s, 2H), 5.45 (s, 2H), 5.50-5.42 (m, 1H), 5.04-4.98 (m, 1H), 5.00 (ddd, JF = 
27.2, JH = 8.6, 1.9, 1H), 3.93 (s, 3H), 3.93 (s, 3H), 3.89 (s, 3H), 3.89 (s, 3H); 13C NMR (126 
MHz; d6-DMSO) δ: 169.05, 169.00, 166.78, 166.58, 156.2, 154.0, 153.8, 148.3, 148.1, 139.7, 
139.3, 128.3, 126.3, 111.2, 110.4, 108.50, 108.47, 89.4 (d, JF = 188.57), 64.0, 63.4, 61.0 (d, JF 
= 217.96), 56.7, 56.5; LRMS (ESI) 584.1 [M-H]-. 
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 (2R,3R)-1-(cyanomethyl) 4-(4,5-dimethoxy-2-nitrobenzyl) 2-((((4,5-dimethoxy-2-
nitrobenzyl)oxy)carbonyl)amino)-3-fluorosuccinate (7). A flame-dried 2-dram vial 
equipped with a stir bar was charged with acid 6 (8 mg). The solid was dissolved in 
chloroacetonitrile (1 mL) and DMF (1 mL) under argon. Triethylamine (1.9 µL) was then 
added slowly as a solution in DMF, and the mixture was stirred under argon for 18 h at 
room temperature. The solvents were then removed in vacuo, and the resulting solid was 
partially purified by silica gel chromatography, giving an orange-tan solid (~3 mg, < 35% 
yield). Purification of product on this scale was difficult, and overlapping signals in the 
mixed 1H NMR made peak assignments impossible. LRMS (ESI) 603.1 [M-H2F]-.  
 
(1S,3R)-1,3-dicarboxy-3-fluoropropan-1-aminium chloride (11). Lactam 10 (15 mg) was 
dissolved in an aqueous 6 N hydrochloric acid solution (1 mL) in a scintillation vial vented 
through an argon bubbler. The mixture was heated at 90 °C for 4 hours, then concentrated 
in vacuo. The resulting residue was twice iteratively redissolved in Millipore water and 
concentrated by lyophilization, giving a crude yellow residue (12 mg), which was carried on 
without further purification.  
H
N
FNvO2C
NVOCO
O
NC
HO2C
H
N
FNvO2C
NVOC
6 7
N
H
O
O
F
OMe
HO2C NH3+
CO2H
F
Cl-
10 11
 94 
 
(2S,4R)-2-((((4,5-dimethoxy-2-nitrobenzyl)oxy)carbonyl)amino)-4-fluoropentanedioic 
acid (12a). Crude amino acid 11 (12 mg) was subjected to the conditions described for 
preparation and purification of NVOC carbamate 4. Following chromatography, fractions 
were concentrated, giving 12a as a yellow solid (3 mg, 8% over 2 steps). 1-H NMR (500 
MHz; CDCl3) δ: 7.74 (s, 1H), 7.20 (s, 1H), 4.99 (d, J = 3.7, 2H), 4.03 (s, 3H), 3.99 (s, 3H), 
2.62-2.59 (m, 1H), 1.57 (m, 3H); LRMS (ESI) 403.1 [M-H]-. 
 
4,5-dimethoxy-2-nitrobenzyl (5-fluoro-2,6-dioxotetrahydro-2H-pyran-3-yl)carbamate 
(13x). A mixture of stereoisomers of NVOC carbamate 12x (20. mg, derived from 4-fluoro-
DL-glutamic acid purchased from Sigma-Aldrich) was added to a pear-shaped flask under 
air, and acetyl chloride (2 mL) was added. The flask was capped with a rubber septum with a 
vent needle, and the suspension was stirred at 55 °C for 2 hours. The mixture was cooled to 
room temperature and stirred overnight, and then concentrated in vacuo. The resulting 
crude mixture was carried on without further purification. LRMS (ESI) 385.1 [M-H]-. 
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Attempted synthesis of 5-((4,5-dimethoxy-2-nitrobenzyl)oxy)-2-((((4,5-dimethoxy-2-
nitrobenzyl)oxy)carbonyl)amino)-4-fluoro-5-oxopentanoic acid (14x). Crude NVOC 
carbamate 13x was dissolved in dry DMF (1 mL) in a scintillation vial. Nitroveratryl alcohol 
(11.5 mg), DMAP (0.6 mg), and triethylamine (6.8 µL) were added under argon. The mixture 
was stirred at 60 °C overnight, and the solvent was removed in vacuo. The correct mass of 
the desired product was observed by LCMS. However, attempts to remove the remaining 
impurities by silica gel chromatography (0-5% acetic acid/ethyl acetate) yielded too little 
product to obtain a 1H NMR or assign the regioisomer by HMBC. LRMS (ESI) 598.1 
[M-H]-. 
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Chapter 5: Progress Toward Mapping Protein-Protein Interfaces With 
Photocrosslinking Non-Canonical Amino Acids  
5.1 Abstract 
 Pentameric ligand-gated ion channels are known to participate in interactions with 
other proteins that regulate their function in vivo. In this chapter, we discuss our efforts to 
establish methods using photochemical crosslinking amino acid analogs to explore these 
protein-protein interfaces. Using the Schultz methodology, we have begun to optimize 
expression and crosslinking conditions in a soluble protein model system: the transcription 
factor estrogen receptor α. We have also successfully incorporated two crosslinking amino 
acids into several pentameric ligand-gated ion channels, including functional serotonin 
receptors. Progress toward development of a mass spectrometry-based readout for 
crosslinking is discussed.  
5.2 Introduction 
5.2.1 Covalent crosslinking with non-canonical amino acids  
Extensive studies of ligand-gated ion channels (LGICs) in model systems have 
revealed detailed pharmacological profiles of many receptor types, contributing to a 
molecular-level understanding of fast synaptic transmission.1,2 However, signal transduction 
at neuronal synapses is mediated by a complex mixture of interacting extracellular, 
membrane-associated, and cytoplasmic molecules; occasionally profiles of individual LGICs 
overlook physiologically relevant aspects of their function. Numerous reports of interactions 
among ligand-gated ion channels have underscored the non-independent nature of receptor 
function – pairs of receptors have been shown to colocalize using fluorescent microscopy, 
and simultaneous activation of different LGICs has often resulted in non-additivity of total 
currents.3-19 It is likely that the same interplay observed in these systems is involved in 
 100 
integrating complex input from a presynaptic cell, but there has been little headway in 
elucidating molecular mechanisms of such crosstalk. 
Direct assessment of interactions among membrane proteins is a challenge, since the 
conformations of the proteins involved and the strength of any interactions are likely 
dependent upon the presence of the lipid bilayer.20 X-ray crystallography and cryo-EM are 
capable of providing very high resolution depictions of these interfaces, but especially in the 
cases of membrane proteins and relatively weak interactions, the observed conformations 
fail to provide the whole story. Coimmunoprecipitation, which is heavily relied upon by 
protein biochemists for low-resolution information about protein complexes, is generally 
performed from a lysate mixture and thus may miss important interactions or reveal spurious 
ones.21 The situation is further complicated by the possibility that receptor-receptor 
interactions are mediated by additional integral membrane and/or cytoplasmic proteins.  
Chemical crosslinking is a potential workaround for these problems, as it allows one 
to preserve information about interactions of interest even after destruction of the native 
cellular environment. Countless bifunctional crosslinking molecules have been developed for 
different applications, including some with isotope labels for easy detection by mass 
spectrometry and/or affinity handles to facilitate purification or imaging.22 Advantages of 
such reagents include their ease of introduction into the system and the potential for 
targeting specific amino acid side chain functionalities. However, they are limited to 
crosslinking solvent-accessible sites at the periphery of binding interfaces, and usually result 
in a highly complex mixture of products. To increase the scope of accessible sites and 
decrease the number of different photoadducts, we have focused on using a site-specific 
crosslinking strategy employing non-canonical amino acid mutagenesis.23,24 Specifically, a 
tyrosine-based tRNA/synthetase has been optimized for incorporation of 4-substituted 
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phenylalanine derivatives, including the commonly used photoreactive crosslinkers 4-
azidophenylalanine (N3Phe) and 4-benzoylphenylalanine (Bpa). This approach uses site-
selective introduction of the crosslinking reagent, which is reactive toward various X-H 
bonds (X = C, N, O, S) or nucleophilic groups (Figure 5.1).25 Furthermore, because N3Phe 
and Bpa are photoreactive, they enable temporal control over the crosslinking reaction.  
Following crosslinking, a number of techniques can be used to analyze products. On 
the simplest level, SDS-PAGE allows detection of higher molecular weight products, with 
immunoprecipitation and/or immunoblotting as options for enrichment or selective 
detection of adducts containing proteins of interest. For higher resolution data, mixtures can 
be subjected to proteolytic digestion, and the resulting fragments identified by tandem mass 
spectrometry. In theory, this procedure could allow for identification of the specific residues 
on the binding partner in contact with the site of incorporation chosen for the crosslinker. 
In practice, low abundance and incomplete fragmentation of crosslinked peptides can often 
make it difficult to achieve the necessary levels of confidence to identify meaningful 
interaction sites. Still, there have been a number of reports using crosslinking and mass 
spectrometry in conjunction.26,27 However, only four have used amino acids incorporated via 
nonsense suppression,28-31 three of which were performed on purified proteins, and none of 
which involved membrane proteins.  
Figure 5.13. Reactivity of photocrosslinking non-canonical amino acids used in this study. (Left) Benzoyl-
phenylalanine (Bpa) is reversibly excited by UV light, and preferentially inserts into C-H bonds adjacent to heteroatoms or 
at tertiary carbons. (Right) 4-Azidophenylalanine (N3Phe) releases dinitrogen after UV excitation, and the resulting nitrene 
can either react via C-H insertion at aryl or alkyl positions, or via rearrangement to an electrophilic species.  
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Of course, we aim to use crosslinking to characterize associations involving LGICs 
in an intact membrane, potentially in a number of different functional states. This goal faces 
a concurrence of several complicating factors, and after initially struggling with our problem 
of primary interest, we chose to optimize our basic experimental design in a simpler model 
system: estrogen receptor α.  
5.2.2 Estrogen receptor α  
There are a number of pathways by which estrogen influences gene expression, 
involving both membrane receptors and internal soluble receptors. Estrogen receptor α 
(ERα) belongs to the latter group, and in its resting state exists in the nucleus as a complex 
with heat shock protein 90 (Hsp90) and other chaperone proteins (Figure 1.4).32 When 
receptor agonists, such as β-estradiol (E2), make their way into the nucleus, they bind to the 
receptor and induce its dissociation from Hsp90. ERα then dimerizes and binds to the 
estrogen response element, a regulatory region of DNA that allows transcription to be 
controlled by the presence of E2 and other agonists.  
 The three-dimensional structure and mechanism of action of ERα are partially 
understood, thanks to numerous crystal structures of the receptor in the presence of various 
ligands. Dimerization is facilitated by two domains: that which is responsible for interaction 
with DNA (the DNA-binding domain, DBD) and that which recognizes and binds to 
agonists or antagonists (the ligand-binding domain, LBD). The structures of the dimeric 
states of these domains have been determined;33,34 the remainder of the protein is disordered 
(Figure 5.2A). 
 The activity of ERα is heavily influenced by its association with coactivator or 
corepressor proteins. The propensity for the receptor to bind different proteins is governed 
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by a peptide recognition domain, activation function 2 (AF2), which forms a hydrophobic 
cleft in the LBD. When an agonist is bound at the LBD, C-terminal helix 12 adopts a 
conformation that allows the AF2 cleft to bind helical peptides from coactivator proteins 
with the consensus sequence LXXLL (Figure 5.2B).35 Antagonists block activity by causing 
helix 12 to either block the AF2 cleft, mimicking the peptides of coactivators (Figure 
5.2C);35 or to dissociate from the receptor in a fashion that favors the binding of helices 
from corepressors, with consensus sequence LXXXLXXXL (Figure 5.2D).36 Current 
efforts to tune the transcriptional activity of ERα and other nuclear receptors focus on the 
Figure 5.14. ERα structure and cofactor interactions. (A) Structural overview of the ERα dimer, showing crystal 
structures for the DBD (PDB 4AA6) and LBD (1A52). Other domains are disordered and shown by dashed lines. (B) 
When agonist is bound, C-terminal helix 12 of the LBD adopts a conformation stabilizing coactivator helical domain 
binding (PDB 3ERD). (C and D) Antagonist binding can cause helix 12 to block the coactivator helix binding site (C, PDB 
3ERT) or allow corepressor helical domain binding (D, PDB 2JF9).   
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design of small molecules that can induce these conformational changes or peptides that can 
stabilize them.  
As our main motivation in studying ERα was to become comfortable with the 
incorporation and reactivity of photochemical crosslinkers, we have used this system as a 
positive control for the viability of our assays, using currently available structures to guide 
our mutagenesis. However, the same methodology could likely be applied as direct readout 
of changes in tertiary structure or recruitment of cofactors in vivo in future work. Indeed, 
two of the aforementioned examples of genetically encoded crosslinkers used in conjunction 
with mass spectrometry explored protein conformation in related nuclear receptors, the 
peroxisome proliferator-activated receptors.28,31 However, these studies used purified 
receptors, and focused exclusively on mapping the conformation of a single subunit, rather 
than protein-protein interactions.  
5.2.3 Pentameric ligand-gated ion channels (pLGICs) 
As the pLGICs have been discussed in depth in Chapters 1-3, we will forgo a 
detailed introduction and give only a brief overview of the specific receptors relevant to the 
following sections.  
There are several classes of serotonin (5-hydroxytryptamine, 5-HT) receptors 
expressed in humans, named 5-HT1 through 5-HT7. Of these, all are 7TM receptors except 
for the 5-HT3 group, which are pLGICs (Figure 1.2).37 There are 5 subunits expressed in the 
human brain, labeled A through E. Functional 5-HT3 receptors can be homopentameric, 
with five A subunits, or heteropentameric, with at least 2 A subunits along with one other 
type of subunit.38 Because the 5-HT3A homopentamer expresses robustly in cultured cells, 
produces strong signals in functional assays, and does not require subunit stoichiometry ratio 
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optimization, much of our preliminary work on crosslinking in pLGICs has been carried out 
in this receptor.  
The nicotinic acetylcholine receptor (nAChR) is a major focus of study for our 
group.39,40 In humans, 16 different genes code for nicotinic receptor subunits (α1-7 and α9-
10, β1-4, γ, δ, and ε), which can be arranged into pentameric arrangements with diverse 
pharmacological properties. Subunits are expressed differentially through regions of the 
central and peripheral nervous system, while signaling at the neuromuscular junction is 
mediated specifically by the muscle-type nAChRs, with stoichiometry (α1)2β1γδ.  
The nAChRs containing the α6 subunit are of particular interest because of the 
recent evidence that their coexpression with the purinergic P2X receptors in dorsal root 
ganglia provides protection against exaggerated pain responses in mice.6 In the same study, 
we have also shown that coactivation of α6-containing nAChRs and P2X receptors results in 
reduction of the total current in the Xenopus laevis oocyte model system. A molecular model 
for this phenomenon has not yet been formulated, and so application of crosslinking to a 
cell culture-based model system could yield very useful information toward this goal. Thus, 
we aimed to establish the technique in the α6β4 and α6β2 receptor subtypes. Because α4-
containing receptors have also been shown to interact with P2X receptors3 and have 
historically been much more amenable to functional expression in model systems, we have 
also attempted to use the α4β4 and α4β2 subtypes. 
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5.3 Results and discussion 
5.3.1 Exploring the ERα ligand-binding domain dimer interface 
5.3.1.1 Nonsense suppression and crosslinking. We began our nonsense suppression 
experiments with an ERα construct containing an N-terminal enhanced GFP (eGFP) fusion. 
Without boiling lysate samples, some fraction of the eGFP remains intact and fluoresces 
even after SDS-PAGE, allowing for rapid evaluation of nonsense suppression and 
crosslinking without the need for western blotting. This is a crude assay, as the proportion of 
fluorescent eGFP need not be identical among all mutants and adducts; however, it has 
dramatically reduced the time required for condition optimization, and a more rigorous 
immunoblotting approach is under way.  
 For the purposes of a positive control, an ideal position for the incorporation of a 
photocrosslinking amino acid analog satisfies a number of conditions. (1) The positioning of 
the probe should be such that irradiation will likely result in crosslinking. The particular 
mechanism of reactivity of the selected analog should be taken into account, including 
functional group preferences for linking partners and the specific atom(s) within the side 
chain that form new bonds. (2) Care should be taken not to disrupt any structurally 
Figure 5.15. LBD residues selected for crosslinking of ERα dimers. Positions used for nonsense suppression are 
shown as black spheres. Side chains on the opposing subunit most likely to react during crosslinking are shown as white 
sticks (PDB 1A52). 
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or functionally important noncovalent interactions. (3) Additional substituents (i.e. N3 or Bz 
for N3Phe or Bpa) should not create steric clashes that disfavor complex formation.  
 X-ray crystallography data for the dimeric ERα ligand-binding domain show a 
number of residues that fit most or all of these criteria (Figure 5.3).33 We performed site-
directed mutagenesis to insert TAG mutations at 5 positions: Thr460, His501, Glu502, 
His516, and Glu523. We also inserted a TAG mutation at an unrelated position in the 
unstructured N-terminal domain, Tyr43, as a negative control for the crosslinking 
experiment.  
We cotransfected HEK293T cells with the mutant constructs, along with either the 
Bpa or N3Phe synthetase plasmid. Following transfection, we supplemented the cell growth 
medium with the appropriate photoreactive amino acid. After allowing protein expression, 
we introduced 10 µM agonist (E2) to induce receptor dimerization, and incubated for 
another 24 h. We then lysed the cells and analyzed them by electrophoresis, imaging via GFP 
fluorescence (Figure 5.4). We observe strong production of a protein at ~75 kD, the same 
apparent molecular weight as the ERα construct. Because nonsense suppression is not 
Figure 5.16. Nonsense suppression in ERα visualized by GFP fluorescence. (A) Results of N3Phe and Bpa 
incorporation at a negative control site. Irradiation of these cells appears to yield no covalent dimer. (B and C) Irradiation of 
cells expressing ERα variants with Bpa (B) or N3Phe (C) incorporated at the LBD, with negative controls.  
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perfectly efficient, a second band also appears at a lower molecular weight, corresponding to 
the truncated product. In negative control lanes lacking the synthetase plasmid, no full-
length protein is observed (Figure 5.4A). However, if the synthetase plasmid is present, 
weak bands do still appear at the molecular weight of the full-length fusion protein even in 
the absence of the non-canonical amino acid supplement (Figure 5.4A,C). This species is 
most likely produced by nonspecific acylation of the suppressor tRNA with tyrosine by the 
mutant synthetase, which was derived from an E. coli tyrosine synthetase. 
 We next subjected the transfected cells to 45 minutes of irradiation at 354 nm with a 
190-mW LED. Analysis of the lysates revealed new bands at high molecular weights, which 
varied in intensity and mobility based on the mutation site and the identity of the crosslinker  
(Figure 5.4B,C). These bands did not appear upon irradiation of cells expressing the 
Y43TAG mutants, which we would not expect to be at the interface of dimerization. 
Moreover, no new products were observed when cells lacking either the amino acid or the 
synthetase were irradiated (controls performed only for the E523N3Phe mutant; data not 
shown).  
 This evidence strongly suggests that the newly formed species are covalently linked 
dimers including at least one ERα subunit. Although the dimerization affinity of the receptor 
should be quite high in the presence of E2,41 it is also possible that the receptor is 
crosslinking with chaperone proteins, transcription cofactors, or other proteins that interact 
Figure 5.17. Confirmation of homodimer crosslinking. To ensure that the observed high molecular weight band 
corresponds to crosslinking of two ERα subunits, we cotransfected receptors containing either nonsense mutations or 
eGFP fusions in ratios of 10:1 and 5:1 (w/w). 
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with the ligand-binding domain. To show that we are capable of forming an adduct between 
two authentic ERα subunits, we used the following experimental approach. Two constructs 
were cotransfected – one containing an N-terminal eGFP fusion without a nonsense 
mutation, and one containing a nonsense mutation, but lacking the fluorescent protein 
fusion (Figure 5.5). After irradiation of these cells and SDS-PAGE, two bands were 
observed – one at the usual size for the full-length eGFP-ERα fusion, and one band at a 
higher molecular weight. Because the eGFP-containing protein lacks a photoreactive amino 
acid, the new band is presumably created specifically by the crosslinking of the invisible ERα 
with the fusion protein. The relative weakness of this band is likely explained by the 
presence of either only one or zero eGFP molecules per adduct, rather than two, as in the 
previous experiments. However, its presence is indicative that the homodimer exists among 
the new bands formed from irradiation, and suggests that the strong band at ~75 kD is 
mostly of this composition. 
5.3.1.2 Time-dependence of photocrosslinking. Presumably, the fraction of dimeric ERα 
observed at completion of the photoreaction should depend upon the thermodynamic 
stability of the noncovalent dimer, providing a potential readout for the effects of mutations 
or ligands on the dimerization equilibrium. Thus, we were curious whether the rate of 
formation of the photoadduct was dependent upon the position or identity of the 
crosslinker. We proceeded with a set of time-course experiments (Figure 5.6). In each test, 
we irradiated dishes of identically transfected and treated HEK293T cells for varying 
durations, followed by immediate lysis and SDS-PAGE. The observed bands corresponding 
to the photoadduct displayed clear time-dependence, which we roughly quantified through 
densitometric analysis. It is worth noting that photobleaching of eGFP is possible during 
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the crosslinking reaction. In an attempt to correct for an overall rate of decay of 
fluorescence, we chose to normalize the densitometry measurements to the sum of the 
integrations for the monomer and adduct bands. At all sites examined, adduct intensity 
increased monotonically over time relative to the full-length monomer band. Interestingly, 
N3Phe and Bpa formed significantly different final proportions of crosslinked dimer when 
incorporated at Glu523. This difference could be due to unfavorable steric clashes 
introduced by the bulky Bpa side chain during dimerization, as the region surrounding this 
residue appears somewhat congested in crystal structures (Figure 5.3).  
We were curious whether the rate of crosslinking was limited by the photon flux of 
the light source, so we also subjected cells expressing E523N3Phe to irradiation with a more 
powerful 1-W LED (Figure 5.6E,F). Interestingly, the crosslinking reaction appeared 
Figure 5.18. Time dependence of photocrosslinking. Time-course experiments for crosslinking of two N3Phe 
mutations (A and B), for two Bpa mutations (C and D), and using a higher-power LED (E and F). All plots show integrated 
band intensities normalized to the sum of the intensities for the monomer and product bands. 
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to reach completion within 20 minutes, but the final proportion of photoadduct was 
somewhat lower than that produced with the 180-mW LED. There was also a significant 
overall decrease in fluorescence in both the monomer and adduct bands after prolonged 
irradiation with the stronger LED, likely due to exacerbated photobleaching of the eGFP 
moiety.   
5.3.1.3 Ligand-dependence of crosslinking. An ideal assay for the thermodynamics of 
receptor activation should be able to corroborate the transcriptional output of the system 
with dimerization over a relevant dynamic range of agonist concentrations. Following 
expression of ERα crosslinking mutants, we treated cells with between 1 nM and 10 µM E2 
before analysis. No significant effect was observed on the final integration of the 
photoadduct band until E2 concentrations dropped to 1 nM (Figure 5.7B,C). This came as 
a surprise, since a previous in vitro monomer exchange study has shown that ERα-LBD 
dimer affinity varies over an E2 concentration range from 10 nM to 1 µM.41 In contrast, the 
agonist response in our system seems to be already saturated once extracellular agonist 
concentrations have reached a threshold of 10 nM. The dynamic range could be modulated 
by the presence of coactivator or corepressor species, which might shift the binding 
equilibrium by sequestering ERα dimers in larger protein complexes. This explanation is in 
line with a recent in vivo fluorescence complementation assay that has produced E2 dose-
Figure 5.19. Ligand dependence of photocrosslinking. (A) In the absence of E2, irradiation results in weaker dimer 
bands than observed in the presence of the ligand. H523N3Phe still produces significant dimer, but noticeably less than 
with 10 µM E2. (B) Results of crosslinking E532N3Phe in the presence of various concentrations of E2. (C) Integrated 
band intensities from (B), normalized to the sum of the values determined for the monomer and dimer bands.  
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response curves closer to what we observe.42 Even in the absence of added E2, some extent 
of covalent dimerization was still observed. This could potentially be due to adventitious 
estrogens present in the cellular growth medium, including components of fetal bovine 
serum or the phenol red pH indicator dye. Efforts to obtain lower baseline signal in the 
absence of added agonist are in progress.  
5.3.2 Progress toward intersubunit crosslinking in the human 5-HT3A receptor 
5.3.2.1 Nonsense suppression and photocrosslinking. Our initial efforts to carry out 
nonsense suppression in 5-HT3A were aimed at finding a positive control for intermolecular 
photocrosslinking. Because a crystal structure of the homopentameric receptor is currently 
available,43 the simplest target was to attempt crosslinking between subunits. We again used a 
fluorescent protein fusion to aid in detection of the receptor following SDS/PAGE. To 
minimize the impact of the fusion on protein structure or oligomerization, we used a 
construct with a CFP inserted into the flexible intracellular loop (see experimental section 
for details). In this case, cell lysis conditions were somewhat more challenging to optimize 
than with the soluble ERα. Despite attempting receptor denaturation with various reducing 
reagents (TCEP, BME, DTT) and solubilization with numerous detergents (NP-40, Triton-
100, Tween-20, SDS, CHAPS, DDM), all lysis conditions resulted in gels with broad, hazy 
bands and what appear to be protein aggregates at high apparent molecular weights. We 
settled on the use of a standard RIPA buffer containing NP-40, SDS, and deoxycholate as 
surfactants. Although this buffer did not successfully disaggregate the high molecular weight 
species, it seemed to be the most effective of those we tried.   
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 Based on the structure of the mouse 5-HT3A receptor, we selected 3 corresponding 
positions in the human receptor that followed the aforementioned criteria for probable 
crosslinking sites: Trp33, Phe199, and Phe222 (Figure 5.8A). We used the same 
tRNA/synthetase pairs as in the ERα system, again transfecting the receptor and synthetase 
plasmids in a 3:1 ratio into HEK293T cells. Although the gels were not as crisp as in the 
ERα model system, we were able to discern a distinct band at the expected molecular weight 
for the 5-HT3A monomer in two of the three mutants (Figure 5.8B). The band was not 
observed in lanes from cells lacking either the non-canonical amino acid or the synthetase 
plasmid, supporting our assignment of the species as full-length monomer. After some 
optimization, we concluded that a 3:1 or 1:1 transfection ratio with ~24-36 h incubation 
produced the greatest intensity of the monomer band (Figure 5.8C,D). A range of 
concentrations of non-canonical amino acid were also tested, but did not seem to 
significantly affect suppression efficiency.  
As in the ERα model system, we then attempted irradiating cells expressing the 
mutant receptors in an effort to crosslink subunits. Although some slight differences in 
Figure 5.20. Nonsense suppression in the 5-HT3A receptor. (A) Crosslinking sites selected at the subunit interfaces of 
the 5-HT3A homopentamer (PDB 4PIR). (B) Full-length subunits containing Bpa or N3Phe at Trp33 and Phe199. (C and 
D) Optimization of transfection ratios (C) and incubation time (D) for maximum expression of mutants. Receptors 
contained a CFP fusion in the M3-M4 loop; images show CFP fluorescence.   
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intensity were observable, the background signal in every gel lane made it impossible to 
discern any distinct bands corresponding to a dimeric or higher order photoadduct. In hopes 
that an immunoblotting detection method might provide less background, we also generated 
mutant receptors containing FLAG epitope tags in the M3-M4 loop and at the N- and C-
termini. Unfortunately, none of the experiments with these mutants yielded convincing 
evidence of nonsense suppression.  
5.3.2.2 Functional validation. Using these conditions, we prepared cells expressing mutant 
receptors for functional validation. For both N3Phe mutants that gave visible monomer 
expression, we observed serotonin-dependent depolarization of plasma membranes (Figure 
5.9). These currents are not as robust as those seen in cells expressing wild type receptors, 
consistent with the relatively low expression levels of the mutants. Interestingly, we saw no 
Figure 5.21. Functional validation of mutant 5-HT3A receptors. Each box shows representative FlexStation3 
fluorescence measurements from FLIPR membrane potential dye-loaded cells in 8 wells of a 96-well plate. Each well 
received a different dose of serotonin after ~25 s of recording. 
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membrane depolarization in cells expressing Bpa-containing receptors. Because monomer 
expression for the two was comparable, this suggests that either receptor assembly or 
function was compromised by the bulky benzoyl substitution introduced by the Bpa group 
at Phe222.  
5.3.2.3 Mass spectrometric analysis.* Although confirming crosslinking by way of 
SDS/PAGE is beyond our present capabilities, we also began exploring the feasibility of 
analyzing 5-HT3A receptors through HPLC-MS2. The ultimate goal of this strategy would be 
to find crosslinked peptide fragments, identify which residues the unnatural crosslinker has 
reacted with, and then use these data to constrain a model of the protein-protein binding 
interface. However, membrane proteins are notoriously difficult to express, purify, digest, 
and ionize. There are several examples of the use of mass spectrometry to gain structural 
information about pLGICs, including the glycine receptor44,45 and the muscle-type nAChR.46 
This section represents our first basic efforts toward obtaining sequence coverage of the wild 
type 5-HT3A receptor.  We attempted two methods for sample preparation: in-gel digestion 
and filter-aided sample preparation (FASP). For each approach, we enriched the receptor via 
immunoprecipitation before proteolytic digestion by targeting an N-terminal FLAG epitope. 
After elution from the beads, the sample was subjected to fractionation by SDS-PAGE. 
Even after immunoprecipitation, the protein content was still not high enough for bands to 
be visible from staining with Coomassie blue, so protein content was located by running a 
second gel in parallel and immunoblotting against the FLAG epitope. Both the gel regions 
corresponding to the protein aggregate and the monomer were excised, and in-gel reduction, 
alkylation, and tryptic digestion were performed (see experimental section for details). After 
                                                
 
* These experiments were carried out with the kind assistance of Caltech’s Proteome Exploration Laboratory.  
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extracting peptides and desalting, the peptides were submitted to HPLC-MS2 using a Thermo 
Orbitrap Fusion instrument.  
 The mass spectrometry analysis returned evidence for seven distinct peptide 
fragments covering 13% of the receptor (Table 5.1). Not surprisingly, all of the peptides 
detected were derived from the more hydrophilic extracellular and intracellular domains. 
Although detected peptides did span one of our chosen nonsense suppression sites (Trp33), 
most peptide intensities were quite low, ~106-107 compared with 109 for the most intense 
contaminant detected. This is somewhat worrisome, as nonsense suppression usually yields 
less protein than cells expressing the wild type receptor, and crosslinking will generate a 
number of different species, further reducing the abundance of each peptide product. 
 In hopes of minimizing the protein lost during gel extraction, we proceeded to 
attempt FASP. Receptors were similarly expressed and enriched using immunoprecipitation, 
Table 5.3. Results of LC-MS2 experiments on the 5-HT3A receptor. Sequence coverage is depicted by regions 
highlighted in red (Run #1, in-gel tryptic digestion) and purple (Run #2, filter-aided chymotryptic digestion). Sites selected 
for mutagenesis are shown as spheres (PDB 4PIR). aPeptides without listed intensities were identified by MS-MS spectra 
triggered by precursor ions of other peptides, so a precursor ion with the matching m/z was not detected or its intensity 
was not recorded. 
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then loaded onto a 10 kD microcentrifuge filter. Following buffer exchange and removal of 
detergents, the adsorbed protein was reduced, alkylated, and digested. In this round of 
sample preparation, we opted to use chymotrypsin rather than trypsin, due to the increased 
number of potential cleavage sites in the transmembrane domain. After the product peptides 
were eluted, dried, and desalted, we again submitted them for HPLC-MS2 analysis, this time 
using a Thermo Fisher Orbitrap Elite instrument. The analysis returned eight distinct 
peptide fragments covering 17% of the protein sequence (Table 5.1). Again, only peptides 
derived from the hydrophilic portions of the receptor were detected. Possibly because of the 
high promiscuity of the chymotryptic digestion, ion intensities were even lower than in the 
results obtained from the in-gel digestion (104-106, while the top 100 ions were 107-1010). 
However, combining the coverage from both preparation procedures, we were able to 
observe peptides covering 59% of the receptor’s extracellular domain and 27% of the entire 
receptor. 
5.3.3 Nonsense suppression in nAChRs  
 Because of our interest in interactions between α6-containing nAChRs and P2X 
receptors, we began by testing nonsense suppression in the α6 subunit. There are no 
available structures of this subunit, so we used the web-based homology-modeling server 
SWISS-MODEL47 to predict the structure of the subunit based upon alignment with the 5-
HT3A receptor structure and sequence (Figure 5.10A). We introduced a C-terminal HA tag 
into the α6 subunit, and then incorporated three TAG mutations at positions that could 
potentially be involved in interactions with other receptors: Tyr142 and His216 in the 
 118 
extracellular domain, and Phe482 in the M4 transmembrane helix (facing out into the lipid 
environment). 
 We cotransfected each of the α6 mutants with the β4 construct and the Bpa 
synthetase plasmid in a ratio of 9:1:2.7, then introduced a solution of Bpa. After 48 h of 
incubation, we lysed the cells, subjected the lysates to SDS-PAGE, and blotted against the 
HA epitope tag. As with the 5-HT3A receptor, the resulting lanes were somewhat smeared. 
Nevertheless, a definite signal was observed at the expected molecular weight of the 
monomer, aligning well with a band in the parent α6 sample (Figure 5.10B). Unfortunately, 
membrane potential dye experiments to validate the function of even the wild type α6β4 
receptor in HEK293T cells revealed no acetylcholine-dependent receptor. Despite clear 
expression of both subunits in the cells, surface protein isolation experiments indicated 
relatively low membrane expression levels of either subunit, possibly causing the lack of 
function we observed.  
Figure 5.22. Nonsense suppression in nAChRs. (A) Homology model of α6 subunits based upon the structure of the 
mouse 5-HT3A receptor. Two solvent-exposed sites selected for nonsense suppression in the ECD are highlighted as red 
spheres; the third site, Phe482, was chosen by sequence alignment of the M4 helix. (B) Western blot against C-terminally 
HA-tagged rat α6L9’S subunits, suppressing with Bpa at each position. Negative control cells were treated only with 
transfection reagent. (C and D) Nonsense suppression with Bpa at Tyr268 in the mouse α4 receptor, containing a GFP-HA 
fusion in the M3-M4 loop, and an L9’A mutation (C), and subsequent attempts at photocrosslinking in cells expressing the 
same mutant (D). The α4 mutant was cotransfected with a β2‡L9’S subunit. Blots were imaged with a mouse primary 
antibody against the HA epitope and a secondary Alexa Fluor 680-conjugated goat antibody. 
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 In the past, our group has had success in elevating the membrane expression levels 
of α6β2 receptors in Xenopus laevis oocytes by introducing gain-of-function L9’S pore 
mutations in both subunits, along with an ER export motif in the intracellular domain of β2 
(notated as β2‡).48 We subcloned the β2‡ gene into our mammalian expression vector and 
cotransfected it along with the α6 plasmid, but again, we observed no acetylcholine-
dependent activity. 
 In contrast, functional expression of α4β4 receptors in HEK293T cells had 
previously been achieved in our group, suggesting that the α6-containing receptors were not 
optimal for these studies. We were indeed able to reproduce acetylcholine-dependent 
membrane depolarization by cotransfecting an α4 construct containing a GFP fusion in the 
M3-M4 loop, along with a wild type β4 construct. Proceeding with the α4-GFP construct, 
we performed a sequence alignment with the 5-HT3A receptor. Based on sequence 
alignment with the 5-HT3A receptor, we selected Tyr268 in the M4 helix, which we expect to 
be lipid-exposed. We were able to easily confirm successful nonsense suppression with both 
N3Phe and Bpa (Figure 5.10C). However, we once again did not detect acetylcholine-
induced membrane depolarization in cells expressing the mutant receptors.  
Interestingly, irradiation of cells expressing the Y268Bpa mutant did appear to 
induce a significant difference in the band pattern observed: the monomer band was reduced 
in intensity, and instead the hazy smear at the top of the lane dramatically increased in 
intensity (Figure 5.10D). This change could possibly be explained by crosslinking of the 
receptor to lipids, resulting in reduced electrophoretic resolution, but further identification 
of any new species was not pursued.   
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5.4 Conclusions 
We have succeeded in using the nonsense suppression approach to incorporate non-
canonical photoreactive amino acids into several proteins in mammalian cells. In the ERα 
system, this has enabled us to crosslink receptor dimers in a fashion that depends upon the 
concentration of activating ligand present. This sets the foundation for informative in vivo 
experiments that could reveal the molecular factors governing interactions with coactivators 
or corepressors that have not yet been crystallized. Optimization of the concentration-
dependent dimerization experiments could also eventually yield a thermodynamic assay for 
receptor activation equilibria. Important steps toward making this type of assay possible will 
include background signal reduction, increasing the dynamic range of the assay, 
improvement of current functional validation tests, and removal of the reliance upon 
fluorescent protein fusions.  
Our nonsense suppression results in pLGICs have also been somewhat promising. 
Although discouraged by the challenges of handling and analyzing highly hydrophobic 
proteins, we have succeeded in introducing crosslinking probes into sites in three different 
pLGIC subunits, including functional 5-HT3A homopentamers. In order for such probes to 
be useful in the investigation of protein-protein interfaces, significant optimization of cell 
lysis, protein denaturation, and electrophoresis conditions may be required. Furthermore, 
prior to extending mass spectrometry techniques to analysis of crosslinker-containing 
receptors, extensive work may be needed to improve the digestion and ionization of receptor 
domains. We advise that future efforts focus first on validation of structurally characterized 
protein-protein interactions with these techniques, ideally involving soluble binding partners 
of the pLGICs.  
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5.5 Experimental procedures 
5.5.1 Molecular biology  
The pcDNA3.1(+) expression vector was used for expression of proteins in 
mammalian cells, and was purchased from Invitrogen (Carlsbad, CA). Genes for human wild 
type 5-HT3A and eGFP-ERα; rat α6L9’S and β2‡L9’S; and mouse α4-GFP and wild type β4 
were subcloned into the vector by restriction digest and subsequent ligation. Small 
modifications, such as introduction of epitope tags or point mutations, were accomplished 
using the QuikChange method (Stratagene). Introduction and removal of GFP fusions were 
carried out using the Q5 mutagenesis kit (New England Biosciences). In the eGFP-ERα 
construct, eGFP was connected to the N-terminus of ERα by way of a 15-residue linker, 
SGRSRAASNSAVDGT. In the mouse α4-GFP construct, the insertion point for the HA-
GFP fusion was between Pro428 and Arg429. 
For nonsense suppression experiments, PU6 plasmids49 encoding the 
tRNA/synthetase pairs for Bpa and N3Phe were a kind gift from the lab of Professor 
Michelle Krogsgaard. These plasmids were amplified and used directly in experiments 
without modification. 
5.5.2 Mammalian cell culture and protein expression 
All incubations were performed at 37 °C under 5% CO2 unless otherwise indicated. 
All manipulations requiring opening of culture flasks or dishes was carried out in a class II 
biosafety cabinet. The growth medium used for human embryonic kidney cells (HEK293T) 
contained 91% DMEM/F12 (Gibco) and 9% heat-inactivated FBS (Gibco), with 100 U/mL 
penicillin and 100 µg/mL streptomycin.  
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HEK293T cells purchased from ATCC were stored as a DMSO suspension at -80 
°C. Freezedowns were immersed in a 37 °C water bath for 2 minutes, until 80% thawed, 
then resuspended with a serological pipet in prewarmed cellular growth medium. The cells 
were then pelleted by centrifuging at 1000 g in a 15-mL conical tube, and the supernatant 
was removed and discarded. Cells were resuspended by gently rocking in 14 mL prewarmed 
growth medium, and then transferred to a T75 flask. Cells were incubated for 24 h, at which 
point the medium was exchanged for 10 mL fresh medium.  
Cells were propagated every 3 days (or whenever they reached 80-90% confluence). 
The old medium was removed, the cells were washed briefly with 10 mL cold phosphate-
buffered saline (PBS), and 1 mL TrypLE dissociation reagent (Gibco) was added. The cells 
were incubated for 5 min to allow for dissociation, then TrypLE was deactivated by addition 
of 9 mL fresh growth medium and cells were resuspended by pipetting forcefully five times 
with a serological pipet. A new T75 flask was filled with 9 mL fresh growth medium, and 1 
mL of the cell suspension was added. The new flask was then gently rocked to ensure even 
distribution of cells on the growth surface, and then returned to incubation.  
Proteins of interest were expressed using the Xfect reagent (Clontech). At the time 
of propagation, 35-mm petri dishes or 6-well plates were seeded by diluting 300 µL of the 
cell suspension into 2.7 mL fresh growth medium. For larger experiments, a 10-cm petri dish 
was seeded by diluting 1 mL of cell suspension into 9 mL fresh growth medium. Cells were 
then incubated until reaching ~50-60% confluence. Before transfecting, the old medium was 
removed and replaced with 1 mL of fresh growth medium (10 mL for a 10-cm plate).  
Transfection mixtures were made by premixing plasmid DNA in the desired 
stoichiometry, diluting with Xfect buffer to a total volume of 100 µL (600 µL for a 10-cm 
dish), and then adding Xfect polymer (0.3 µL/µg plasmid DNA). Typical total DNA loading 
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was 10 µg for a 35-mm dish or 30 µg for a 10-cm dish. Following incubation at room 
temperature for 10 min, the entire transfection mixture was added dropwise to the dish, 
which was then rocked gently to ensure homogeneity. The cells were then incubated for 4 
hours before the transfection reagent was removed and replaced with 3 mL fresh growth 
medium. For nonsense suppression experiments, the media added after transfection 
contained 0.05 mM Bpa or 0.5 mM N3Phe. 
 
5.5.3 Photocrosslinking  
Photocrosslinking experiments were performed only on cells seeded in individual 35-
mm dishes to allow for independent UV irradiation. After incubation for 24-48 h, medium 
was removed, the cells were rinsed once gently with fresh growth medium to remove 
residual extracellular photoreactive amino acids, and then 1 mL of fresh medium added. The 
dishes were then irradiated from below with a 190-mW 365 nm LED for the desired 
crosslinking duration, using a ring stand with two clamps to ensure consistent positioning 
among experiments. For ERα experiments, E2 was added directly to the growth medium 24 
h following transfection to induce receptor dimerization, and irradiation was carried out after 
another 24 h. 
 
5.5.4 Lysis, immunoprecipitation, SDS-PAGE, and immunoblotting 
Following protein expression (and, if desired, crosslinking), media were removed and 
discarded. Lysis buffers were selected based on the application. For ERα experiments, 1% 
SDS in PBS was used. For most pLGIC experiments, a RIPA buffer (1% NP-40, 0.5% 
sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 50 mM Tris HCl, pH 8.0) was used. In 
experiments requiring enrichment by immunoprecipitation, 1% Triton X-100 in PBS was 
used to avoid denaturation of antibodies. The desired lysis buffer (typically 300 µL for a 35-
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mm dish or 1 mL for a 10-cm dish) was then added, and the cells were gathered using a 1-
mL pipette tip or disposable cell scraper, then transferred to a 1.5-mL Eppendorf tube. 
Lysates were homogenized with an immersion sonicator for 10 s, then stored at -80 °C or 
used immediately. 
Immunoprecipitations were carried out using immobilized protein A/G agarose 
(Pierce). For each 10 cm plate of HEK293T cells, 100 µL resin was washed 3 times with lysis 
buffer. 300 µL of Triton X-100 was used for lysis of each plate. Following sonication, 
samples were centrifuged and supernatant was transferred to the resin, where it was 
incubated overnight at 4 °C with rocking. The resin was then washed 3 times for 5 minutes 
each with lysis buffer, before eluting with 250 µL of 3xFLAG peptide (150 ng/µL) for 1 h at 
4 °C. A second identical elution was then performed to remove remaining protein, and 
samples were used directly for SDS-PAGE fractionation or FASP.  
For most experiments, precast Biorad Mini-Protean TGX 15-well gels with an 
AnykD gradient were used, running samples for ~1 h at 150 V. Fluorescent protein fusions 
were imaged immediately using a Typhoon FLA 9000 with 473 nm laser excitation and an 
LPB (510LP) detection filter. For immunoblotting, gels were transferred to LF-PVDF 
membranes, blocked using 5% milk in PBS with 0.1% Tween-20 (PBST) for 1 hour, and 
then blotted overnight with a solution of the appropriate primary antibody in the same 
blocking medium. Membranes were then washed 4 x 10 min with PBST, treated with a 
solution of an Alexa Fluor 680-conjugated secondary antibody in blocking medium for 1 
hour, and washed again 4 x 10 min before imaging on a LI-COR Odyssey with 685 nm laser 
excitation and 700 nm detection. Densitometric analysis was performed using ImageJ.   
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5.5.6 Membrane potential dye assay 
Immediately following transfection, cells in 6-well plates or 35-cm dishes were 
dissociated with 300 µL TrypLE per well (or 1 mL, for 10-cm dishes). After incubation for 5 
min, the cells were resuspended in 2.7 mL fresh growth medium (containing Bpa or N3Phe, 
if necessary) with a 1-mL pipette tip (or 9 mL, for 10-cm dishes). The suspension was then 
transferred to a V-shaped basin. A multichannel pipet was used to plate 100 µL of the 
suspension into each well in three rows of a clear-bottom 96-well culture plate (or into all 96 
wells, for a 10-cm dish). The cells were then incubated for 24-48 h before performing the 
functional assay. 
  Thirty minutes prior to the experiment, growth medium was removed from all wells 
by a multichannel pipet and discarded. The cells were then loaded with the commercially 
available FLIPR Blue Assay Kit membrane potential dye (Molecular Devices). The solid dye 
was dissolved as recommended by the manufacturer, and then diluted 1:1 in Flex buffer (115 
mM NaCl, 1 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM D-glucose, and 10 mM HEPES at 
pH 7.5)50 and transferred to a V-shaped basin. A multichannel pipette was used to add 100 
µL to each well, and the plate was incubated for 30 min. Data collection was performed 
using the FlexStation3 in Flex mode. Fluorescence readings were taken from each well every 
1.52 s for a total of 180 s. After ~25 s, 100 µL of ligand solution was added to each well via 
the liquid handler arm. Data were processed using Microsoft Excel, at which point a 
constant baseline correction corresponding to the mean signal observed prior to ligand 
addition was subtracted from the trace for each well.  
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5.5.7 Proteolysis and HPLC-MS analysis 
For in-gel digestions, work was performed in a laminar-flow workspace. Gel pieces 
were excised and placed into Eppendorf tubes. Sample processing was performed as 
optimized by Caltech’s Proteome Exploration Laboratory (PEL). Briefly, gel pieces were 
destained with acetontrile, reduced with DTT, alkylated with iodoacetamide, digested with 
trypsin, extracted with acetonitrile and formic acid, and then desalted using a C18 Ziptip 
(Millipore). For a detailed procedure, see the PEL website (pel.caltech.edu). 
 For FASP, eluted proteins from immunoprecipitation were applied to a 10 kD size-
exclusion spin column. Reduction, alkylation, digestion, and elution were carried out as 
previously described.51 Peptides were desalted by flowing through a C18 plug.  
 Peptide samples were fractionated by HPLC and analyzed using Thermo Scientific 
Orbitrap Elite or Orbitrap Fusion instruments, according to protocols optimized by the 
PEL.52 Specific procedures are available upon request.  
Data were analyzed using the MaxQuant software, searching against the sequence for 
the human 5-HT3A receptor and a contaminant database (246 entries). The digestion enzyme 
was specified as either trypsin or chymotrypsin, depending on the sample preparation, using 
up to 2 missed cleavages. Variable modifications included methionine oxidation (+15.9949) 
and N-terminal protein acylation (+42.0106), with a fixed modification of cysteine 
carbamidomethylation (+57.0215). Precursor mass tolerance was less than 4.5 ppm. False 
discovery rates were fixed at 1% and estimated using a decoy database search performed by 
MaxQuant. 
5.6 References 
1. Dacosta, C. J. B. & Baenziger, J. E. Gating of pentameric ligand-gated ion channels: structural insights 
and ambiguities. Structure 21, 1271–1283 (2013). 
2. Nys, M., Kesters, D. & Ulens, C. Structural insights into Cys-loop receptor function and ligand 
 127 
recognition. Biochem. Pharmacol. 86, 1042–1053 (2013). 
3. Khakh, B. S. et al. An angstrom scale interaction between plasma membrane ATP-gated P2X2 and 
α4β2 nicotinic channels measured with fluorescence resonance energy transfer and total internal 
reflection fluorescence microscopy. J. Neurosci. 25, 6911–6920 (2005). 
4. Shrivastava, A. N., Triller, A., Sieghart, W. & Sarto-Jackson, I. Regulation of GABAA Receptor 
Dynamics by Interaction with Purinergic P2X2 Receptors. J. Biol. Chem. 286, 14455–14468 (2011). 
5. Birdsong, W. T. et al. Sensing Muscle Ischemia: Coincident Detection of Acid and ATP via Interplay of 
Two Ion Channels. Neuron 68, 739–749 (2010). 
6. Wieskopf, J. S. et al. The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via 
cross-inhibition of P2X2/3 receptors. Sci. Transl. Med. 7, 287ra72–287ra72 (2015). 
7. Toulmé, E. et al. An intracellular motif of P2X3 receptors is required for functional cross‐talk with 
GABAA receptors in nociceptive DRG neurons. 102, 1357–1368 (2007). 
8. Boué-Grabot, E., Toulmé, E., Emerit, M. B. & Garret, M. Subunit-specific coupling between gamma-
aminobutyric acid type A and P2X2 receptor channels. J. Biol. Chem. 279, 52517–52525 (2004). 
9. Boué-Grabot, E. et al. Cross-talk and co-trafficking between ρ1/GABA receptors and ATP-gated 
channels. J. Biol. Chem. 279, 6967–6975 (2004). 
10. Boué-Grabot, E. et al. Intracellular cross talk and physical interaction between two classes of 
neurotransmitter-gated channels. J. Neurosci. 23, 1246-1253 (2003). 
11. Li, Y. & Xu, T.-L. State-dependent cross-inhibition between anionic GABAA and glycine ionotropic 
receptors in rat hippocampal CA1 neurons. Neuroreport 13, 223 (2002). 
12. Nakazawa, K. ATP-activated current and its interaction with acetylcholine-activated current in rat 
sympathetic neurons. J. Neurosci. 14, 740-750 (1994).  
13. Sokolova, E., Nistri, A. & Giniatullin, R. Negative cross talk between anionic GABAA and cationic 
P2X ionotropic receptors of rat dorsal root ganglion neurons. J. Neurosci. 21, 4958-4968 (2001). 
14. Decker, D. A. & Galligan, J. J. Cross-inhibition between nicotinic acetylcholine receptors and P2X 
receptors in myenteric neurons and HEK-293 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 296, 
G1267–76 (2009). 
15. Decker, D. A. & Galligan, J. J. Molecular mechanisms of cross-inhibition between nicotinic 
acetylcholine receptors and P2X receptors in myenteric neurons and HEK-293 cells. Neurogastroenterol. 
Motil. 22, 901–8– e235 (2010). 
16. Karanjia, R. et al. Cross-inhibitory interactions between GABAA and P2X channels in myenteric 
neurones. Eur. J. Neurosci. 23, 3259–3268 (2006). 
17. Barajas-López, C., Montaño, L. M. & Espinosa-Luna, R. Inhibitory interactions between 5-HT3 and 
P2X channels in submucosal neurons. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G1238–48 (2002). 
18. Barajas-López, C., Espinosa-Luna, R. & Zhu, Y. Functional interactions between nicotinic and P2X 
channels in short-term cultures of guinea-pig submucosal neurons. J. Physiol. (Lond.) 513, 671–683 
(1998). 
19. Zhou, X. & Galligan, J. J. Non-additive interaction between nicotinic cholinergic and P2X purine 
receptors in guinea-pig enteric neurons in culture. J. Physiol. (Lond.) 513, 685–697 (1998). 
20. Skach, W. R. Cellular mechanisms of membrane protein folding. Nat. Struct. Mol. Biol. 16, 606–612 
(2009). 
21. Avila, J. R., Lee, J. S. & Toriia, K. U. Co-Immunoprecipitation of Membrane-Bound Receptors. The 
Arabidopsis Book 13, e0180 (2015). 
22. Paramelle, D., Miralles, G., Subra, G. & Martinez, J. Chemical cross‐linkers for protein structure 
studies by mass spectrometry. Proteomics 13, 438–456 (2013). 
23. Chin, J. W. & Schultz, P. G. In vivo photocrosslinking with unnatural amino Acid mutagenesis. 
Chembiochem 3, 1135–1137 (2002). 
24. Farrell, I. S., Toroney, R., Hazen, J. L., Mehl, R. A. & Chin, J. W. Photo-cross-linking interacting 
proteins with a genetically encoded benzophenone. Nat Meth 2, 377–384 (2005). 
25. Tanaka, Y., Bond, M. R. & Kohler, J. J. Photocrosslinkers illuminate interactions in living cells. Mol. 
Biosyst. 4, 473–480 (2008). 
26. Sinz, A., Arlt, C., Chorev, D. & Sharon, M. Chemical cross-linking and native mass spectrometry: A 
fruitful combination for structural biology. Protein Sci. 24, 1193–1209 (2015). 
27. Sinz, A. Investigation of protein–protein interactions in living cells by chemical crosslinking and mass 
spectrometry. Anal. Bioanal. Chem. 397, 3433–3440 (2010). 
28. Schwarz, R. et al. Monitoring Conformational Changes in Peroxisome Proliferator-Activated Receptor 
α by a Genetically Encoded Photoamino Acid, Cross-Linking, and Mass Spectrometry. J. Med. Chem. 
 128 
56, 4252–4263 (2013). 
29. Forné, I. et al. Probing the conformation of the ISWI ATPase domain with genetically encoded 
photoreactive crosslinkers and mass spectrometry. Mol. Cell Proteomics 11, M111.012088–M111.012088 
(2012). 
30. Berg, M. et al. An In Vivo Photo-Cross-Linking Approach Reveals a Homodimerization Domain of 
Aha1 in S. cerevisiae. PLoS ONE 9, e89436 (2014). 
31. Schwarz, R., Tänzler, D., Ihling, C. H. & Sinz, A. Monitoring Solution Structures of Peroxisome 
Proliferator-Activated Receptor β/δ upon Ligand Binding. PLoS ONE 11, e0151412 (2016). 
32. Fliss, A. E., Benzeno, S., Rao, J. & Caplan, A. J. Control of estrogen receptor ligand binding by Hsp90. 
J. Steroid Biochem. 72, 223-230 (2000). 
33. Tanenbaum, D. M., Wang, Y., Williams, S. P. & Sigler, P. B. Crystallographic comparison of the 
estrogen and progesterone receptor's ligand binding domains. Proc. Natl. Acad. Sci. U.S.A. 95, 5998–
6003 (1998). 
34. Schwabe, J. W., Chapman, L. & Rhodes, D. The oestrogen receptor recognizes an imperfectly 
palindromic response element through an alternative side-chain conformation. Structure 3, 201–213 
(1995). 
35. Shiau, A. K. et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism 
of this interaction by tamoxifen. Cell 95, 927–937 (1998). 
36. Heldring, N. et al. Structural insights into corepressor recognition by antagonist-bound estrogen 
receptors. J. Biol. Chem. 282, 10449–10455 (2007). 
37. Thompson, A. J. & Lummis, S. C. R. 5-HT3 Receptors. Curr. Pharm. Design 12, 3615-3630 (2006). 
38. Niesler, B. et al. Characterization of the novel human serotonin receptor subunits 5-HT3C, 5-HT3D, 
and 5-HT3E. Mol. Pharmacol. 72, 8–17 (2007). 
39. Van Arnam, E. B. & Dougherty, D. A. Functional probes of drug-receptor interactions implicated by 
structural studies: Cys-loop receptors provide a fertile testing ground. J. Med. Chem. 57, 6289–6300 
(2014). 
40. Albuquerque, E. X., Pereira, E. F. R., Alkondon, M. & Rogers, S. W. Mammalian Nicotinic 
Acetylcholine Receptors: From Structure to Function. Physiol. Rev. 89, 73–120 (2009). 
41. Tamrazi, A. et al. Estrogen Receptor Dimerization: Ligand Binding Regulates Dimer Affinity and 
DimerDissociation Rate. Mol. Endocrinol. 16, 2706–2719 (2013). 
42. McLachlan, M. J., Katzenellenbogen, J. A. & Zhao, H. A new fluorescence complementation biosensor 
for detection of estrogenic compounds. Biotechnol. Bioeng. 108, 2794–2803 (2011). 
43. Hassaine, G. et al. X-ray structure of the mouse serotonin 5-HT3 receptor. Nature 512, 276–281 (2014). 
44. Leite, J. F., Amoscato, A. A. & Cascio, M. Coupled proteolytic and mass spectrometry studies indicate 
a novel topology for the glycine receptor. J. Biol. Chem. 275, 13683–13689 (2000). 
45. Liu, Z. et al. Crosslinking constraints and computational models as complementary tools in modeling 
the extracellular domain of the glycine receptor. PLoS ONE 9, e102571 (2014). 
46. Leite, J. F. et al. Conformation-dependent hydrophobic photolabeling of the nicotinic receptor: 
Electrophysiology-coordinated photochemistry and mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 
100, 13054–13059 (2003). 
47. Biasini, M. et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using 
evolutionary information. Nucleic Acids Res. 42, gku340–W258 (2014). 
48. Post, M. R., Limapichat, W., Lester, H. A. & Dougherty, D. A. Heterologous expression and nonsense 
suppression provide insights into agonist behavior at α6β2 nicotinic acetylcholine receptors. 
Neuropharmacology 97, 376–382 (2015). 
49. Wang, W. et al. Quantitative analysis of T cell receptor complex interaction sites using genetically 
encoded photo-cross-linkers. ACS Chem. Biol. 9, 2165–2172 (2014). 
50. Lummis, S. C. R., Thompson, A. J., Bencherif, M. & Lester, H. A. Varenicline Is a Potent Agonist of 
the Human 5-Hydroxytryptamine3 Receptor. J. Pharmacol. Exp. Ther. 339, 125–131 (2011). 
51. Erde, J., Loo, R. R. O. & Loo, J. A. Enhanced FASP (eFASP) to Increase Proteome Coverage and 
Sample Recovery for Quantitative Proteomic Experiments. J. Proteome Res. 13, 1885-1895 (2014). 
52. Kalli, A., Smith, G. T., Sweredoski, M. J. & Hess, S. Evaluation and optimization of mass 
spectrometric settings during data-dependent acquisition mode: focus on LTQ-Orbitrap mass 
analyzers. J. Proteome Res. 12, 3071–3086 (2013). 
 
